BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 679578 Cn1cc2cc(NC(=O)c3coc4CCNC(=O)c34)ccc2n1 InChI=1S/C16H14N4O3/c1-20-7-9-6-10(2-3-12(9)19-20)18-15(21)11-8-23-13-4-5-17-16(22)14(11)13/h2-3,6-8H,4-5H2,1H3,(H,17,22)(H,18,21) GDJXCKXRSLVHQE-UHFFFAOYSA-N 344036 N-(2-methyl-2H-indazol-5-yl)-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 1 High affinity nerve growth factor receptor Human 44.2 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344036 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344036&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252861 385450124 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679579 CN1CCc2occ(C(=O)Nc3ccc4nn(C)cc4c3)c2C1=O InChI=1S/C17H16N4O3/c1-20-6-5-14-15(17(20)23)12(9-24-14)16(22)18-11-3-4-13-10(7-11)8-21(2)19-13/h3-4,7-9H,5-6H2,1-2H3,(H,18,22) LRIXPAKXRLDUKW-UHFFFAOYSA-N 344108 5-methyl-N-(2-methyl-2H-indazol-5-yl)-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 2 High affinity nerve growth factor receptor Human 60.2 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344108 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344108&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252767 385450196 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679580 O=C(Nc1ccc(cc1)N1CCOCC1)c1coc2CCNC(=O)c12 InChI=1S/C18H19N3O4/c22-17(14-11-25-15-5-6-19-18(23)16(14)15)20-12-1-3-13(4-2-12)21-7-9-24-10-8-21/h1-4,11H,5-10H2,(H,19,23)(H,20,22) HJZQJYGJRLYVCE-UHFFFAOYSA-N 344109 N-[4-(morpholin-4-yl)phenyl]-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 3 High affinity nerve growth factor receptor Human 173 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344109 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344109&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253130 385450197 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679581 CN1CCc2occ(C(=O)Nc3ccc(C)cc3)c2C1=O InChI=1S/C16H16N2O3/c1-10-3-5-11(6-4-10)17-15(19)12-9-21-13-7-8-18(2)16(20)14(12)13/h3-6,9H,7-8H2,1-2H3,(H,17,19) GFKQKDRRQBWQTP-UHFFFAOYSA-N 344110 5-methyl-N-(4-methylphenyl)-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 4 High affinity nerve growth factor receptor Human 375 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344110 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344110&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252791 385450198 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679582 COc1cc(ccc1NC(=O)c1coc2CCNC(=O)c12)N1CCN(CC1)C(=O)OC(C)(C)C InChI=1S/C24H30N4O6/c1-24(2,3)34-23(31)28-11-9-27(10-12-28)15-5-6-17(19(13-15)32-4)26-21(29)16-14-33-18-7-8-25-22(30)20(16)18/h5-6,13-14H,7-12H2,1-4H3,(H,25,30)(H,26,29) GELAPHZQPQTPEP-UHFFFAOYSA-N 344111 US9777020, Example 5::tert-butyl 4-(3-methoxy-4-{[(4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridin-3-yl)carbonyl]amino}phenyl)piperazine-1-carboxylate High affinity nerve growth factor receptor Human 54.4 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344111 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344111&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252857 385450199 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679583 COc1cc(ccc1NC(=O)c1coc2CCNC(=O)c12)N1CCNCC1 InChI=1S/C19H22N4O4/c1-26-16-10-12(23-8-6-20-7-9-23)2-3-14(16)22-18(24)13-11-27-15-4-5-21-19(25)17(13)15/h2-3,10-11,20H,4-9H2,1H3,(H,21,25)(H,22,24) FQHIDLMHUHPPHK-UHFFFAOYSA-N 344112 N-[2-methoxy-4-(piperazin-1-yl)phenyl]-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 6 High affinity nerve growth factor receptor Human 46.7 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344112 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344112&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253125 385450200 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679584 COc1nc(ccc1NC(=O)c1coc2CCCNC(=O)c12)N1CCN(C)CC1 InChI=1S/C20H25N5O4/c1-24-8-10-25(11-9-24)16-6-5-14(20(23-16)28-2)22-18(26)13-12-29-15-4-3-7-21-19(27)17(13)15/h5-6,12H,3-4,7-11H2,1-2H3,(H,21,27)(H,22,26) ONUDQEKVQVSRSY-UHFFFAOYSA-N 344113 N-[2-methoxy-6-(4-methylpiperazin-1-yl)pyridin-3-yl]-4-oxo-5,6,7,8-tetrahydro-4H-furo[3,2-c]azepine-3-carboxamide::US9777020, Example 7 High affinity nerve growth factor receptor Human 212 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344113 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344113&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252921 385450201 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679585 CCOc1nc(ccc1NC(=O)c1coc2CCN(CCOCc3ccccc3)C(=O)c12)N1CCN(CC1)C(C)=O InChI=1S/C30H35N5O6/c1-3-40-29-24(9-10-26(32-29)34-15-13-33(14-16-34)21(2)36)31-28(37)23-20-41-25-11-12-35(30(38)27(23)25)17-18-39-19-22-7-5-4-6-8-22/h4-10,20H,3,11-19H2,1-2H3,(H,31,37) HGAWQTGRZRSYJM-UHFFFAOYSA-N 344114 N-[6-(4-acetylpiperazin-1-yl)-2-ethoxypyridin-3-yl]-5-[2-(benzyloxy)ethyl]-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 8 High affinity nerve growth factor receptor Human 69.5 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344114 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344114&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253072 385450202 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679586 CCOc1nc(ccc1NC(=O)c1coc2CCN(CCO)C(=O)c12)N1CCN(CC1)C(C)=O InChI=1S/C23H29N5O6/c1-3-33-22-17(4-5-19(25-22)27-10-8-26(9-11-27)15(2)30)24-21(31)16-14-34-18-6-7-28(12-13-29)23(32)20(16)18/h4-5,14,29H,3,6-13H2,1-2H3,(H,24,31) BXLZREQIIYWPFZ-UHFFFAOYSA-N 344115 N-[6-(4-acetylpiperazin-1-yl)-2-ethoxypyridin-3-yl]-5-(2-hydroxyethyl)-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 9 High affinity nerve growth factor receptor Human 5.10 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344115 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344115&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253079 385450203 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679587 CC(=O)N1CCN(CC1)c1ccc(NC(=O)c2coc3CCNC(=O)c23)cc1 InChI=1S/C20H22N4O4/c1-13(25)23-8-10-24(11-9-23)15-4-2-14(3-5-15)22-19(26)16-12-28-17-6-7-21-20(27)18(16)17/h2-5,12H,6-11H2,1H3,(H,21,27)(H,22,26) NCZUKJAVIKMGFU-UHFFFAOYSA-N 344116 N-[4-(4-acetylpiperazin-1-yl)phenyl]-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 10 High affinity nerve growth factor receptor Human 55.9 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344116 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344116&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252918 385450204 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679588 Cn1ncc2cc(NC(=O)c3coc4CCNC(=O)c34)ccc12 InChI=1S/C16H14N4O3/c1-20-12-3-2-10(6-9(12)7-18-20)19-15(21)11-8-23-13-4-5-17-16(22)14(11)13/h2-3,6-8H,4-5H2,1H3,(H,17,22)(H,19,21) YZEQKTWHCBTLBC-UHFFFAOYSA-N 344117 N-(1-methyl-1H-indazol-5-yl)-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 11 High affinity nerve growth factor receptor Human 64.0 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344117 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344117&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253077 385450205 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679589 O=C(Nc1ccc2[nH]cnc2c1)c1coc2CCNC(=O)c12 InChI=1S/C15H12N4O3/c20-14(9-6-22-12-3-4-16-15(21)13(9)12)19-8-1-2-10-11(5-8)18-7-17-10/h1-2,5-7H,3-4H2,(H,16,21)(H,17,18)(H,19,20) BDIJDJMTXYGLCF-UHFFFAOYSA-N 344118 N-(1H-benzimidazol-5-yl)-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 12 High affinity nerve growth factor receptor Human 99.6 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344118 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344118&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253140 385450206 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679590 NC(=O)c1ccc(NC(=O)c2coc3CCNC(=O)c23)cc1 InChI=1S/C15H13N3O4/c16-13(19)8-1-3-9(4-2-8)18-14(20)10-7-22-11-5-6-17-15(21)12(10)11/h1-4,7H,5-6H2,(H2,16,19)(H,17,21)(H,18,20) MXNAYOORVBVXDO-UHFFFAOYSA-N 344119 N-(4-carbamoylphenyl)-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 13 High affinity nerve growth factor receptor Human 166 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344119 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344119&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252939 385450207 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679591 O=C(Nc1ccc2[nH]ncc2c1)c1coc2CCNC(=O)c12 InChI=1S/C15H12N4O3/c20-14(10-7-22-12-3-4-16-15(21)13(10)12)18-9-1-2-11-8(5-9)6-17-19-11/h1-2,5-7H,3-4H2,(H,16,21)(H,17,19)(H,18,20) IMRPWCFYBTYYMH-UHFFFAOYSA-N 344120 N-(1H-indazol-5-yl)-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 14 High affinity nerve growth factor receptor Human 111 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344120 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344120&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252850 385450208 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679592 Cc1nc2ccc(NC(=O)c3coc4CCNC(=O)c34)cc2s1 InChI=1S/C16H13N3O3S/c1-8-18-11-3-2-9(6-13(11)23-8)19-15(20)10-7-22-12-4-5-17-16(21)14(10)12/h2-3,6-7H,4-5H2,1H3,(H,17,21)(H,19,20) WMFBWSYGLDMWDG-UHFFFAOYSA-N 344121 N-(2-methyl-1,3-benzothiazol-6-yl)-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 15 High affinity nerve growth factor receptor Human 69.3 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344121 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344121&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252756 385450209 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679593 CN1CCN(CC1)c1ccc(NC(=O)c2coc3CCNC(=O)c23)nc1 InChI=1S/C18H21N5O3/c1-22-6-8-23(9-7-22)12-2-3-15(20-10-12)21-17(24)13-11-26-14-4-5-19-18(25)16(13)14/h2-3,10-11H,4-9H2,1H3,(H,19,25)(H,20,21,24) KERSRMVRYAHXDQ-UHFFFAOYSA-N 344122 N-[5-(4-methylpiperazin-1-yl)pyridin-2-yl]-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 16 High affinity nerve growth factor receptor Human 279 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344122 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344122&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253143 385450210 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679594 CN1CCN(CC1)c1ccc(NC(=O)c2coc3CCNC(=O)c23)cc1 InChI=1S/C19H22N4O3/c1-22-8-10-23(11-9-22)14-4-2-13(3-5-14)21-18(24)15-12-26-16-6-7-20-19(25)17(15)16/h2-5,12H,6-11H2,1H3,(H,20,25)(H,21,24) BOHOVNGMZOXLGQ-UHFFFAOYSA-N 344123 N-[4-(4-methylpiperazin-1-yl)phenyl]-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 17 High affinity nerve growth factor receptor Human 81.4 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344123 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344123&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252806 385450211 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679595 COc1cc(ccc1NC(=O)c1coc2CCNC(=O)c12)N1CCN(CC1)C(C)=O InChI=1S/C21H24N4O5/c1-13(26)24-7-9-25(10-8-24)14-3-4-16(18(11-14)29-2)23-20(27)15-12-30-17-5-6-22-21(28)19(15)17/h3-4,11-12H,5-10H2,1-2H3,(H,22,28)(H,23,27) LCHBNEKHAXACNA-UHFFFAOYSA-N 344124 N-[4-(4-acetylpiperazin-1-yl)-2-methoxyphenyl]-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 18 High affinity nerve growth factor receptor Human 59.8 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344124 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344124&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252822 385450212 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679596 CCOc1nc(ccc1NC(=O)c1coc2CCNC(=O)c12)N1CCN(CC1)C(C)=O InChI=1S/C21H25N5O5/c1-3-30-21-15(4-5-17(24-21)26-10-8-25(9-11-26)13(2)27)23-19(28)14-12-31-16-6-7-22-20(29)18(14)16/h4-5,12H,3,6-11H2,1-2H3,(H,22,29)(H,23,28) GDGGPAKZEJJLTH-UHFFFAOYSA-N 344125 N-[6-(4-acetylpiperazin-1-yl)-2-ethoxypyridin-3-yl]-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 19 High affinity nerve growth factor receptor Human 16.3 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344125 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344125&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253167 385450213 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679597 COCCOc1nc(ccc1NC(=O)c1coc2CCNC(=O)c12)N1CCN(CC1)C(C)=O InChI=1S/C22H27N5O6/c1-14(28)26-7-9-27(10-8-26)18-4-3-16(22(25-18)32-12-11-31-2)24-20(29)15-13-33-17-5-6-23-21(30)19(15)17/h3-4,13H,5-12H2,1-2H3,(H,23,30)(H,24,29) MXSDYTJRDUNOOG-UHFFFAOYSA-N 344126 N-[6-(4-acetylpiperazin-1-yl)-2-(2-methoxyethoxyl)pyridin-3-yl]-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 20 High affinity nerve growth factor receptor Human 25.9 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344126 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344126&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252975 385450214 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679598 CC(=O)N1CCN(CC1)c1ccc(NC(=O)c2coc3CCNC(=O)c23)c(OC2COC2)n1 InChI=1S/C22H25N5O6/c1-13(28)26-6-8-27(9-7-26)18-3-2-16(22(25-18)33-14-10-31-11-14)24-20(29)15-12-32-17-4-5-23-21(30)19(15)17/h2-3,12,14H,4-11H2,1H3,(H,23,30)(H,24,29) IDYVAQAFGSOJPK-UHFFFAOYSA-N 344127 N-[6-(4-acetylpiperazin-1-yl)-2-(oxetan-3-yloxy)pyridin-3-yl]-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 21 High affinity nerve growth factor receptor Human 21.6 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344127 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344127&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253028 385450215 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679599 CN1CCN(CC1)c1ccc(NC(=O)c2coc3CCN(C)C(=O)c23)cc1 InChI=1S/C20H24N4O3/c1-22-9-11-24(12-10-22)15-5-3-14(4-6-15)21-19(25)16-13-27-17-7-8-23(2)20(26)18(16)17/h3-6,13H,7-12H2,1-2H3,(H,21,25) KABYSZAEEABEJU-UHFFFAOYSA-N 344128 5-methyl-N-[4-(4-methylpiperazin-1-yl)phenyl]-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 22 High affinity nerve growth factor receptor Human 200 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344128 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344128&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252835 385450216 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679600 CN1CCc2occ(C(=O)Nc3ccc4[nH]ncc4c3)c2C1=O InChI=1S/C16H14N4O3/c1-20-5-4-13-14(16(20)22)11(8-23-13)15(21)18-10-2-3-12-9(6-10)7-17-19-12/h2-3,6-8H,4-5H2,1H3,(H,17,19)(H,18,21) DNSFQPBRWDHZCD-UHFFFAOYSA-N 344129 N-(1H-indazol-5-yl)-5-methyl-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 23 High affinity nerve growth factor receptor Human 257 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344129 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344129&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252931 385450217 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679601 CN1CCc2occ(C(=O)Nc3ccc4n(C)ncc4c3)c2C1=O InChI=1S/C17H16N4O3/c1-20-6-5-14-15(17(20)23)12(9-24-14)16(22)19-11-3-4-13-10(7-11)8-18-21(13)2/h3-4,7-9H,5-6H2,1-2H3,(H,19,22) CKXIYBOEXLSSKH-UHFFFAOYSA-N 344130 5-methyl-N-(1-methyl-1H-indazol-5-yl)-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 24 High affinity nerve growth factor receptor Human 189 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344130 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344130&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252887 385450218 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679602 CN1CCc2occ(C(=O)Nc3ccc(cc3)N3CCOCC3)c2C1=O InChI=1S/C19H21N3O4/c1-21-7-6-16-17(19(21)24)15(12-26-16)18(23)20-13-2-4-14(5-3-13)22-8-10-25-11-9-22/h2-5,12H,6-11H2,1H3,(H,20,23) WFHTWJINFMWYRI-UHFFFAOYSA-N 344131 5-methyl-N-[4-(morpholin-4-yl)phenyl]-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 25 High affinity nerve growth factor receptor Human 112 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344131 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344131&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252953 385450219 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679603 CN1CCc2occ(C(=O)Nc3ccc(cc3)C(N)=O)c2C1=O InChI=1S/C16H15N3O4/c1-19-7-6-12-13(16(19)22)11(8-23-12)15(21)18-10-4-2-9(3-5-10)14(17)20/h2-5,8H,6-7H2,1H3,(H2,17,20)(H,18,21) MHSPZDWYZRJKOA-UHFFFAOYSA-N 344132 N-(4-carbamoylphenyl)-5-methyl-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 26 High affinity nerve growth factor receptor Human 202 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344132 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344132&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253118 385450220 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679604 CN1CCc2occ(C(=O)Nc3ccc4[nH]cnc4c3)c2C1=O InChI=1S/C16H14N4O3/c1-20-5-4-13-14(16(20)22)10(7-23-13)15(21)19-9-2-3-11-12(6-9)18-8-17-11/h2-3,6-8H,4-5H2,1H3,(H,17,18)(H,19,21) KHUISGMWSLZACO-UHFFFAOYSA-N 344133 N-(1H-benzimidazol-5-yl)-5-methyl-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 27 High affinity nerve growth factor receptor Human 428 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344133 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344133&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252798 385450221 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679605 CN1CCc2occ(C(=O)Nc3ccc(cc3)N3CCN(CC3)C(C)=O)c2C1=O InChI=1S/C21H24N4O4/c1-14(26)24-9-11-25(12-10-24)16-5-3-15(4-6-16)22-20(27)17-13-29-18-7-8-23(2)21(28)19(17)18/h3-6,13H,7-12H2,1-2H3,(H,22,27) IAGQBWYJLPJKNZ-UHFFFAOYSA-N 344134 N-[4-(4-acetylpiperazin-1-yl)phenyl]-5-methyl-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 28 High affinity nerve growth factor receptor Human 110 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344134 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344134&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253146 385450222 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679606 CN1CCc2occ(C(=O)Nc3ccc4nc(C)sc4c3)c2C1=O InChI=1S/C17H15N3O3S/c1-9-18-12-4-3-10(7-14(12)24-9)19-16(21)11-8-23-13-5-6-20(2)17(22)15(11)13/h3-4,7-8H,5-6H2,1-2H3,(H,19,21) WPHGJMNAHTYGMY-UHFFFAOYSA-N 344135 5-methyl-N-(2-methyl-1,3-benzothiazol-6-yl)-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 29 High affinity nerve growth factor receptor Human 169 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344135 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344135&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252849 385450223 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679607 Cc1ccc(NC(=O)c2coc3CCNC(=O)c23)cc1 InChI=1S/C15H14N2O3/c1-9-2-4-10(5-3-9)17-14(18)11-8-20-12-6-7-16-15(19)13(11)12/h2-5,8H,6-7H2,1H3,(H,16,19)(H,17,18) WHAABQIDQYHTCT-UHFFFAOYSA-N 344136 N-(4-methylphenyl)-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 30 High affinity nerve growth factor receptor Human 521 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344136 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344136&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253112 385450224 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679608 Oc1ccc(NC(=O)c2coc3CCNC(=O)c23)cc1 InChI=1S/C14H12N2O4/c17-9-3-1-8(2-4-9)16-13(18)10-7-20-11-5-6-15-14(19)12(10)11/h1-4,7,17H,5-6H2,(H,15,19)(H,16,18) USLFPGQDQXSFTE-UHFFFAOYSA-N 344137 N-(4-hydroxyphenyl)-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 31 High affinity nerve growth factor receptor Human 390 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344137 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344137&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252966 385450225 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679609 CC(=O)Nc1ccc(NC(=O)c2coc3CCNC(=O)c23)cc1 InChI=1S/C16H15N3O4/c1-9(20)18-10-2-4-11(5-3-10)19-15(21)12-8-23-13-6-7-17-16(22)14(12)13/h2-5,8H,6-7H2,1H3,(H,17,22)(H,18,20)(H,19,21) OKZUNBKNDJGAFZ-UHFFFAOYSA-N 344138 N-(4-acetamidophenyl)-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 32 High affinity nerve growth factor receptor Human 554 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344138 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344138&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253092 385450226 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679610 O=C(Nc1ccc2ncccc2c1)c1coc2CCNC(=O)c12 InChI=1S/C17H13N3O3/c21-16(12-9-23-14-5-7-19-17(22)15(12)14)20-11-3-4-13-10(8-11)2-1-6-18-13/h1-4,6,8-9H,5,7H2,(H,19,22)(H,20,21) FRGQPPMRPACURZ-UHFFFAOYSA-N 344139 4-oxo-N-(quinolin-6-yl)-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 33 High affinity nerve growth factor receptor Human 111 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344139 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344139&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252830 385450227 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679611 O=C(Nc1ccc2cn[nH]c2c1)c1coc2CCNC(=O)c12 InChI=1S/C15H12N4O3/c20-14(10-7-22-12-3-4-16-15(21)13(10)12)18-9-2-1-8-6-17-19-11(8)5-9/h1-2,5-7H,3-4H2,(H,16,21)(H,17,19)(H,18,20) AYGFMJXWGWASDP-UHFFFAOYSA-N 344140 N-(1H-indazol-6-yl)-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 34 High affinity nerve growth factor receptor Human 910 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344140 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344140&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252768 385450228 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679612 COc1ccc(NC(=O)c2coc3CCNC(=O)c23)c(OC)n1 InChI=1S/C15H15N3O5/c1-21-11-4-3-9(15(18-11)22-2)17-13(19)8-7-23-10-5-6-16-14(20)12(8)10/h3-4,7H,5-6H2,1-2H3,(H,16,20)(H,17,19) RXFRBECAYCWZHB-UHFFFAOYSA-N 344141 N-(2,6-dimethoxypyridin-3-yl)-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 35 High affinity nerve growth factor receptor Human 117 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344141 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344141&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252990 385450229 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679613 O=C(Nc1ccon1)c1coc2CCNC(=O)c12 InChI=1S/C11H9N3O4/c15-10(13-8-2-4-18-14-8)6-5-17-7-1-3-12-11(16)9(6)7/h2,4-5H,1,3H2,(H,12,16)(H,13,14,15) NVSBICXCWPDVPO-UHFFFAOYSA-N 344142 N-(1,2-oxazol-3-yl)-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 36 High affinity nerve growth factor receptor Human 8010 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344142 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344142&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252898 385450230 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679614 O=C(Nc1cnccn1)c1coc2CCNC(=O)c12 InChI=1S/C12H10N4O3/c17-11(16-9-5-13-3-4-14-9)7-6-19-8-1-2-15-12(18)10(7)8/h3-6H,1-2H2,(H,15,18)(H,14,16,17) MTVNJPKCRAJCLS-UHFFFAOYSA-N 344143 4-oxo-N-(pyrazin-2-yl)-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 37 High affinity nerve growth factor receptor Human 3210 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344143 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344143&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253057 385450231 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679615 Cc1cc(NC(=O)c2coc3CCNC(=O)c23)no1 InChI=1S/C12H11N3O4/c1-6-4-9(15-19-6)14-11(16)7-5-18-8-2-3-13-12(17)10(7)8/h4-5H,2-3H2,1H3,(H,13,17)(H,14,15,16) UQJLJPOXYGNSCU-UHFFFAOYSA-N 344144 N-(5-methyl-1,2-oxazol-3-yl)-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 38 High affinity nerve growth factor receptor Human 1720 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344144 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344144&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253027 385450232 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679616 O=C(Nc1ccc(cc1)C#N)c1coc2CCNC(=O)c12 InChI=1S/C15H11N3O3/c16-7-9-1-3-10(4-2-9)18-14(19)11-8-21-12-5-6-17-15(20)13(11)12/h1-4,8H,5-6H2,(H,17,20)(H,18,19) BVZYDNHNNPVFEW-UHFFFAOYSA-N 344145 N-(4-cyanophenyl)-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 39 High affinity nerve growth factor receptor Human 430 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344145 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344145&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253041 385450233 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679617 Fc1ccc(NC(=O)c2coc3CCNC(=O)c23)nc1 InChI=1S/C13H10FN3O3/c14-7-1-2-10(16-5-7)17-12(18)8-6-20-9-3-4-15-13(19)11(8)9/h1-2,5-6H,3-4H2,(H,15,19)(H,16,17,18) KIQNOWNEJOBUOZ-UHFFFAOYSA-N 344146 N-(5-fluoropyridin-2-yl)-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 40 High affinity nerve growth factor receptor Human 3240 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344146 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344146&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252803 385450234 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679618 COc1ccc(NC(=O)c2coc3CCNC(=O)c23)cn1 InChI=1S/C14H13N3O4/c1-20-11-3-2-8(6-16-11)17-13(18)9-7-21-10-4-5-15-14(19)12(9)10/h2-3,6-7H,4-5H2,1H3,(H,15,19)(H,17,18) HRULUAKDUDWOKO-UHFFFAOYSA-N 344147 N-(6-methoxypyridin-3-yl)-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 41 High affinity nerve growth factor receptor Human 1390 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344147 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344147&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252947 385450235 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679619 Clc1ccc(NC(=O)c2coc3CCNC(=O)c23)nc1 InChI=1S/C13H10ClN3O3/c14-7-1-2-10(16-5-7)17-12(18)8-6-20-9-3-4-15-13(19)11(8)9/h1-2,5-6H,3-4H2,(H,15,19)(H,16,17,18) GDJKEYIRBYHXSJ-UHFFFAOYSA-N 344148 N-(5-chloropyridin-2-yl)-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 42 High affinity nerve growth factor receptor Human 918 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344148 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344148&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252858 385450236 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679620 O=C(Nc1cccc(c1)C#N)c1coc2CCNC(=O)c12 InChI=1S/C15H11N3O3/c16-7-9-2-1-3-10(6-9)18-14(19)11-8-21-12-4-5-17-15(20)13(11)12/h1-3,6,8H,4-5H2,(H,17,20)(H,18,19) SKUQVYBYWJBCRD-UHFFFAOYSA-N 344149 N-(3-cyanophenyl)-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 43 High affinity nerve growth factor receptor Human 5640 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344149 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344149&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252783 385450237 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679621 CCOc1ccc(NC(=O)c2coc3CCNC(=O)c23)cn1 InChI=1S/C15H15N3O4/c1-2-21-12-4-3-9(7-17-12)18-14(19)10-8-22-11-5-6-16-15(20)13(10)11/h3-4,7-8H,2,5-6H2,1H3,(H,16,20)(H,18,19) YOOFTBLJBPUHQM-UHFFFAOYSA-N 344150 N-(6-ethoxypyridin-3-yl)-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 44 High affinity nerve growth factor receptor Human 4470 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344150 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344150&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253194 385450238 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679622 Cc1n[nH]c2ccc(NC(=O)c3coc4CCNC(=O)c34)cc12 InChI=1S/C16H14N4O3/c1-8-10-6-9(2-3-12(10)20-19-8)18-15(21)11-7-23-13-4-5-17-16(22)14(11)13/h2-3,6-7H,4-5H2,1H3,(H,17,22)(H,18,21)(H,19,20) OVCCMYVBAKWFNI-UHFFFAOYSA-N 344151 N-(3-methyl-1H-indazol-5-yl)-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 45 High affinity nerve growth factor receptor Human 3480 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344151 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344151&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253024 385450239 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679623 Cc1cc2[nH]ncc2cc1NC(=O)c1coc2CCNC(=O)c12 InChI=1S/C16H14N4O3/c1-8-4-12-9(6-18-20-12)5-11(8)19-15(21)10-7-23-13-2-3-17-16(22)14(10)13/h4-7H,2-3H2,1H3,(H,17,22)(H,18,20)(H,19,21) BWXLMZDAJLMAJS-UHFFFAOYSA-N 344152 N-(6-methyl-1H-indazol-5-yl)-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 46 High affinity nerve growth factor receptor Human 855 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344152 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344152&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252936 385450240 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679624 O=C(Nc1nc2ccccc2s1)c1coc2CCNC(=O)c12 InChI=1S/C15H11N3O3S/c19-13(8-7-21-10-5-6-16-14(20)12(8)10)18-15-17-9-3-1-2-4-11(9)22-15/h1-4,7H,5-6H2,(H,16,20)(H,17,18,19) SQZNNGCYYRTECI-UHFFFAOYSA-N 344153 N-(1,3-benzothiazol-2-yl)-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 47 High affinity nerve growth factor receptor Human 1220 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344153 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344153&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253155 385450241 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679625 COC(=O)c1n[nH]c2ccc(NC(=O)c3coc4CCNC(=O)c34)cc12 InChI=1S/C17H14N4O5/c1-25-17(24)14-9-6-8(2-3-11(9)20-21-14)19-15(22)10-7-26-12-4-5-18-16(23)13(10)12/h2-3,6-7H,4-5H2,1H3,(H,18,23)(H,19,22)(H,20,21) SEYCYBWRDCMVHD-UHFFFAOYSA-N 344154 US9777020, Example 48::methyl 5-{[(4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridin-3-yl)carbonyl]amino}-1H-indazole-3-carboxylate High affinity nerve growth factor receptor Human 506 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344154 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344154&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252955 385450242 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679626 CCN(CC)c1ccc(NC(=O)c2coc3CCNC(=O)c23)cc1 InChI=1S/C18H21N3O3/c1-3-21(4-2)13-7-5-12(6-8-13)20-17(22)14-11-24-15-9-10-19-18(23)16(14)15/h5-8,11H,3-4,9-10H2,1-2H3,(H,19,23)(H,20,22) HNCQVNOWNSFGMO-UHFFFAOYSA-N 344155 N-[4-(diethylamino)phenyl]-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 49 High affinity nerve growth factor receptor Human 631 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344155 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344155&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252785 385450243 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679627 CC(O)Cn1ncc2cc(NC(=O)c3coc4CCNC(=O)c34)ccc12 InChI=1S/C18H18N4O4/c1-10(23)8-22-14-3-2-12(6-11(14)7-20-22)21-17(24)13-9-26-15-4-5-19-18(25)16(13)15/h2-3,6-7,9-10,23H,4-5,8H2,1H3,(H,19,25)(H,21,24) BZSPDMCCTXONRX-UHFFFAOYSA-N 344156 N-[1-(2-hydroxypropyl)-1H-indazol-5-yl]-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 50 High affinity nerve growth factor receptor Human 90.7 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344156 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344156&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252957 385450244 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679628 CS(=O)(=O)NCCn1cc2cc(NC(=O)c3coc4CCNC(=O)c34)ccc2n1 InChI=1S/C18H19N5O5S/c1-29(26,27)20-6-7-23-9-11-8-12(2-3-14(11)22-23)21-17(24)13-10-28-15-4-5-19-18(25)16(13)15/h2-3,8-10,20H,4-7H2,1H3,(H,19,25)(H,21,24) GZLRJIWLLIJJEV-UHFFFAOYSA-N 344157 N-(2-{2-[(methylsulfonyl)amino]ethyl}-2H-indazol-5-yl)-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 51 High affinity nerve growth factor receptor Human 18.9 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344157 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344157&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252770 385450245 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679629 CN1CCN(CCn2cc3cc(NC(=O)c4coc5CCNC(=O)c45)ccc3n2)CC1 InChI=1S/C22H26N6O3/c1-26-6-8-27(9-7-26)10-11-28-13-15-12-16(2-3-18(15)25-28)24-21(29)17-14-31-19-4-5-23-22(30)20(17)19/h2-3,12-14H,4-11H2,1H3,(H,23,30)(H,24,29) UFKBWTXOTZUUMU-UHFFFAOYSA-N 344158 N-{2-[2-(4-methylpiperazin-1-yl)ethyl]-2H-indazol-5-yl}-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 52 High affinity nerve growth factor receptor Human 18.4 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344158 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344158&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252894 385450246 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679630 OCCn1ncc2cc(NC(=O)c3coc4CCNC(=O)c34)ccc12 InChI=1S/C17H16N4O4/c22-6-5-21-13-2-1-11(7-10(13)8-19-21)20-16(23)12-9-25-14-3-4-18-17(24)15(12)14/h1-2,7-9,22H,3-6H2,(H,18,24)(H,20,23) HUVRRDHJFZMXAK-UHFFFAOYSA-N 344159 N-[1-(2-hydroxyethyl)-1H-indazol-5-yl]-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 53 High affinity nerve growth factor receptor Human 67.5 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344159 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344159&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252902 385450247 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679631 O=C(Nc1ccc2n(CCN3CCCC3)ncc2c1)c1coc2CCNC(=O)c12 InChI=1S/C21H23N5O3/c27-20(16-13-29-18-5-6-22-21(28)19(16)18)24-15-3-4-17-14(11-15)12-23-26(17)10-9-25-7-1-2-8-25/h3-4,11-13H,1-2,5-10H2,(H,22,28)(H,24,27) SSUYPROGJPXCPU-UHFFFAOYSA-N 344160 4-oxo-N-{1-[2-(pyrrolidin-1-yl)ethyl]-1H-indazol-5-yl}-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 54 High affinity nerve growth factor receptor Human 108 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344160 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344160&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252842 385450248 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679632 CC(O)Cn1cc2cc(NC(=O)c3coc4CCNC(=O)c34)ccc2n1 InChI=1S/C18H18N4O4/c1-10(23)7-22-8-11-6-12(2-3-14(11)21-22)20-17(24)13-9-26-15-4-5-19-18(25)16(13)15/h2-3,6,8-10,23H,4-5,7H2,1H3,(H,19,25)(H,20,24) OSWZWKDFFNISQM-UHFFFAOYSA-N 344161 N-[2-(2-hydroxypropyl)-2H-indazol-5-yl]-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 55 High affinity nerve growth factor receptor Human 20.8 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344161 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344161&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252998 385450249 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679633 O=C(Nc1ccc2n(CCN3CCOCC3)ncc2c1)c1coc2CCNC(=O)c12 InChI=1S/C21H23N5O4/c27-20(16-13-30-18-3-4-22-21(28)19(16)18)24-15-1-2-17-14(11-15)12-23-26(17)6-5-25-7-9-29-10-8-25/h1-2,11-13H,3-10H2,(H,22,28)(H,24,27) GJVOEFYNMPUYDM-UHFFFAOYSA-N 344162 N-{1-[2-(morpholin-4-yl)ethyl]-1H-indazol-5-yl}-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 56 High affinity nerve growth factor receptor Human 48.5 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344162 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344162&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252926 385450250 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679634 CN1CCN(CCn2ncc3cc(NC(=O)c4coc5CCNC(=O)c45)ccc23)CC1 InChI=1S/C22H26N6O3/c1-26-6-8-27(9-7-26)10-11-28-18-3-2-16(12-15(18)13-24-28)25-21(29)17-14-31-19-4-5-23-22(30)20(17)19/h2-3,12-14H,4-11H2,1H3,(H,23,30)(H,25,29) HYVPWJDRLRVOIZ-UHFFFAOYSA-N 344163 N-{1-[2-(4-methylpiperazin-1-yl)ethyl]-1H-indazol-5-yl}-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 57 High affinity nerve growth factor receptor Human 34.6 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344163 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344163&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252758 385450251 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679635 CS(=O)(=O)NCCn1ncc2cc(NC(=O)c3coc4CCNC(=O)c34)ccc12 InChI=1S/C18H19N5O5S/c1-29(26,27)21-6-7-23-14-3-2-12(8-11(14)9-20-23)22-17(24)13-10-28-15-4-5-19-18(25)16(13)15/h2-3,8-10,21H,4-7H2,1H3,(H,19,25)(H,22,24) WVWRHFLZIGQCGJ-UHFFFAOYSA-N 344164 N-(1-{2-[(methylsulfonyl)amino]ethyl}-1H-indazol-5-yl)-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 58 High affinity nerve growth factor receptor Human 105 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344164 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344164&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253075 385450252 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679636 CN1CCc2occ(C(=O)Nc3ccc(O)cc3)c2C1=O InChI=1S/C15H14N2O4/c1-17-7-6-12-13(15(17)20)11(8-21-12)14(19)16-9-2-4-10(18)5-3-9/h2-5,8,18H,6-7H2,1H3,(H,16,19) RBIIPFRULDUKKY-UHFFFAOYSA-N 344165 N-(4-hydroxyphenyl)-5-methyl-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 59 High affinity nerve growth factor receptor Human 984 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344165 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344165&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252979 385450253 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679637 CN1CCc2occ(C(=O)Nc3ccc(NC(C)=O)cc3)c2C1=O InChI=1S/C17H17N3O4/c1-10(21)18-11-3-5-12(6-4-11)19-16(22)13-9-24-14-7-8-20(2)17(23)15(13)14/h3-6,9H,7-8H2,1-2H3,(H,18,21)(H,19,22) VKZQXHYPLNUIBO-UHFFFAOYSA-N 344166 N-(4-acetamidophenyl)-5-methyl-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 60 High affinity nerve growth factor receptor Human 2110 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344166 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344166&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252941 385450254 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679638 CN1CCc2occ(C(=O)Nc3ccc(cc3)N3CCCCC3)c2C1=O InChI=1S/C20H23N3O3/c1-22-12-9-17-18(20(22)25)16(13-26-17)19(24)21-14-5-7-15(8-6-14)23-10-3-2-4-11-23/h5-8,13H,2-4,9-12H2,1H3,(H,21,24) PVTOBEDWNGMSEI-UHFFFAOYSA-N 344167 5-methyl-4-oxo-N-[4-(piperidin-1-yl)phenyl]-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 61 High affinity nerve growth factor receptor Human 195 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344167 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344167&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252961 385450255 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679639 CN1CCc2occ(C(=O)Nc3cnc4ccccc4c3)c2C1=O InChI=1S/C18H15N3O3/c1-21-7-6-15-16(18(21)23)13(10-24-15)17(22)20-12-8-11-4-2-3-5-14(11)19-9-12/h2-5,8-10H,6-7H2,1H3,(H,20,22) PWEQGBYSRDRXFV-UHFFFAOYSA-N 344168 5-methyl-4-oxo-N-(quinolin-3-yl)-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 62 High affinity nerve growth factor receptor Human 827 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344168 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344168&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253161 385450256 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679640 CN1CCc2occ(C(=O)Nc3ccc4ncccc4c3)c2C1=O InChI=1S/C18H15N3O3/c1-21-8-6-15-16(18(21)23)13(10-24-15)17(22)20-12-4-5-14-11(9-12)3-2-7-19-14/h2-5,7,9-10H,6,8H2,1H3,(H,20,22) XOXKLBXXPMOUIM-UHFFFAOYSA-N 344169 5-methyl-4-oxo-N-(quinolin-6-yl)-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 63 High affinity nerve growth factor receptor Human 319 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344169 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344169&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252799 385450257 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679641 CN1CCc2occ(C(=O)Nc3ccc4cn[nH]c4c3)c2C1=O InChI=1S/C16H14N4O3/c1-20-5-4-13-14(16(20)22)11(8-23-13)15(21)18-10-3-2-9-7-17-19-12(9)6-10/h2-3,6-8H,4-5H2,1H3,(H,17,19)(H,18,21) JZVHMRGNUSBOHE-UHFFFAOYSA-N 344170 N-(1H-indazol-6-yl)-5-methyl-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 64 High affinity nerve growth factor receptor Human 134 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344170 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344170&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253136 385450258 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679642 COc1ccc(NC(=O)c2coc3CCN(C)C(=O)c23)c(OC)n1 InChI=1S/C16H17N3O5/c1-19-7-6-11-13(16(19)21)9(8-24-11)14(20)17-10-4-5-12(22-2)18-15(10)23-3/h4-5,8H,6-7H2,1-3H3,(H,17,20) UGVQGFJAXLENLO-UHFFFAOYSA-N 344171 N-(2,6-dimethoxypyridin-3-yl)-5-methyl-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 65 High affinity nerve growth factor receptor Human 146 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344171 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344171&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252982 385450259 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679643 CN1CCc2occ(C(=O)Nc3cc(C)on3)c2C1=O InChI=1S/C13H13N3O4/c1-7-5-10(15-20-7)14-12(17)8-6-19-9-3-4-16(2)13(18)11(8)9/h5-6H,3-4H2,1-2H3,(H,14,15,17) DBIXUYGXIVWXTL-UHFFFAOYSA-N 344172 5-methyl-N-(5-methyl-1,2-oxazol-3-yl)-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 66 High affinity nerve growth factor receptor Human 5080 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344172 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344172&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252962 385450260 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679644 CN1CCc2occ(C(=O)Nc3ccc(cc3)C#N)c2C1=O InChI=1S/C16H13N3O3/c1-19-7-6-13-14(16(19)21)12(9-22-13)15(20)18-11-4-2-10(8-17)3-5-11/h2-5,9H,6-7H2,1H3,(H,18,20) KIFYUULZRZSUCP-UHFFFAOYSA-N 344173 N-(4-cyanophenyl)-5-methyl-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 67 High affinity nerve growth factor receptor Human 1080 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344173 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344173&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252837 385450261 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679645 CN1CCc2occ(C(=O)Nc3ccc(F)cn3)c2C1=O InChI=1S/C14H12FN3O3/c1-18-5-4-10-12(14(18)20)9(7-21-10)13(19)17-11-3-2-8(15)6-16-11/h2-3,6-7H,4-5H2,1H3,(H,16,17,19) XUOSMOMVJOVFAN-UHFFFAOYSA-N 344174 N-(5-fluoropyridin-2-yl)-5-methyl-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 68 High affinity nerve growth factor receptor Human 5820 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344174 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344174&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252864 385450262 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679646 COc1ccc(NC(=O)c2coc3CCN(C)C(=O)c23)cn1 InChI=1S/C15H15N3O4/c1-18-6-5-11-13(15(18)20)10(8-22-11)14(19)17-9-3-4-12(21-2)16-7-9/h3-4,7-8H,5-6H2,1-2H3,(H,17,19) PVTWHMQPOOOVHW-UHFFFAOYSA-N 344175 N-(6-methoxypyridin-3-yl)-5-methyl-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 69 High affinity nerve growth factor receptor Human 4340 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344175 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344175&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252833 385450263 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679647 CN1CCc2occ(C(=O)Nc3ccc(Cl)cn3)c2C1=O InChI=1S/C14H12ClN3O3/c1-18-5-4-10-12(14(18)20)9(7-21-10)13(19)17-11-3-2-8(15)6-16-11/h2-3,6-7H,4-5H2,1H3,(H,16,17,19) BPHFIWVTTORRDW-UHFFFAOYSA-N 344176 N-(5-chloropyridin-2-yl)-5-methyl-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 70 High affinity nerve growth factor receptor Human 2490 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344176 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344176&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253061 385450264 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679648 CN1CCc2occ(C(=O)Nc3cccc(c3)C#N)c2C1=O InChI=1S/C16H13N3O3/c1-19-6-5-13-14(16(19)21)12(9-22-13)15(20)18-11-4-2-3-10(7-11)8-17/h2-4,7,9H,5-6H2,1H3,(H,18,20) HARUHMHURWMWDZ-UHFFFAOYSA-N 344177 N-(3-cyanophenyl)-5-methyl-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 71 High affinity nerve growth factor receptor Human 3670 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344177 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344177&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252969 385450265 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679649 CCOc1ccc(NC(=O)c2coc3CCN(C)C(=O)c23)cn1 InChI=1S/C16H17N3O4/c1-3-22-13-5-4-10(8-17-13)18-15(20)11-9-23-12-6-7-19(2)16(21)14(11)12/h4-5,8-9H,3,6-7H2,1-2H3,(H,18,20) ATVOHKJOVAHXQS-UHFFFAOYSA-N 344178 N-(6-ethoxypyridin-3-yl)-5-methyl-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 72 High affinity nerve growth factor receptor Human 2480 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344178 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344178&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252883 385450266 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679650 CN1CCc2occ(C(=O)Nc3ccc4[nH]nc(C)c4c3)c2C1=O InChI=1S/C17H16N4O3/c1-9-11-7-10(3-4-13(11)20-19-9)18-16(22)12-8-24-14-5-6-21(2)17(23)15(12)14/h3-4,7-8H,5-6H2,1-2H3,(H,18,22)(H,19,20) AOZURHWKMVOKGC-UHFFFAOYSA-N 344179 5-methyl-N-(3-methyl-1H-indazol-5-yl)-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 73 High affinity nerve growth factor receptor Human 1080 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344179 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344179&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253123 385450267 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679651 CN1CCc2occ(C(=O)Nc3cc4cn[nH]c4cc3C)c2C1=O InChI=1S/C17H16N4O3/c1-9-5-13-10(7-18-20-13)6-12(9)19-16(22)11-8-24-14-3-4-21(2)17(23)15(11)14/h5-8H,3-4H2,1-2H3,(H,18,20)(H,19,22) KZLGANJFNCIPGM-UHFFFAOYSA-N 344180 5-methyl-N-(6-methyl-1H-indazol-5-yl)-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 74 High affinity nerve growth factor receptor Human 2590 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344180 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344180&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253101 385450268 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679652 CN1CCc2occ(C(=O)Nc3nc4ccccc4s3)c2C1=O InChI=1S/C16H13N3O3S/c1-19-7-6-11-13(15(19)21)9(8-22-11)14(20)18-16-17-10-4-2-3-5-12(10)23-16/h2-5,8H,6-7H2,1H3,(H,17,18,20) GGBHXCOJYPLLTB-UHFFFAOYSA-N 344181 N-(1,3-benzothiazol-2-yl)-5-methyl-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 75 High affinity nerve growth factor receptor Human 2050 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344181 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344181&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252844 385450269 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679653 CN1CCc2occ(C(=O)Nc3ccc(cn3)C(F)(F)F)c2C1=O InChI=1S/C15H12F3N3O3/c1-21-5-4-10-12(14(21)23)9(7-24-10)13(22)20-11-3-2-8(6-19-11)15(16,17)18/h2-3,6-7H,4-5H2,1H3,(H,19,20,22) HKVQTWOCHDONNW-UHFFFAOYSA-N 344182 5-methyl-4-oxo-N-[5-(trifluoromethyl)pyridin-2-yl]-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 76 High affinity nerve growth factor receptor Human 1530 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344182 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344182&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252823 385450270 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679654 CN1CCc2occ(C(=O)Nc3cc4cn[nH]c4cc3Cl)c2C1=O InChI=1S/C16H13ClN4O3/c1-21-3-2-13-14(16(21)23)9(7-24-13)15(22)19-12-4-8-6-18-20-11(8)5-10(12)17/h4-7H,2-3H2,1H3,(H,18,20)(H,19,22) RVBZXBGEQVDKRW-UHFFFAOYSA-N 344183 N-(6-chloro-1H-indazol-5-yl)-5-methyl-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 77 High affinity nerve growth factor receptor Human 367 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344183 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344183&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253002 385450271 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679655 CN1CCc2occ(C(=O)Nc3ccc4[nH]c(C)nc4c3)c2C1=O InChI=1S/C17H16N4O3/c1-9-18-12-4-3-10(7-13(12)19-9)20-16(22)11-8-24-14-5-6-21(2)17(23)15(11)14/h3-4,7-8H,5-6H2,1-2H3,(H,18,19)(H,20,22) PROSUOCULTUSSW-UHFFFAOYSA-N 344184 5-methyl-N-(2-methyl-1H-benzimidazol-5-yl)-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 78 High affinity nerve growth factor receptor Human 236 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344184 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344184&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253067 385450272 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679656 COc1cc(ccc1NC(=O)c1coc2CCNC(=O)c12)N1CCN(CC1)C(=O)CC(C)(C)C InChI=1S/C25H32N4O5/c1-25(2,3)14-21(30)29-11-9-28(10-12-29)16-5-6-18(20(13-16)33-4)27-23(31)17-15-34-19-7-8-26-24(32)22(17)19/h5-6,13,15H,7-12,14H2,1-4H3,(H,26,32)(H,27,31) DBKQCYYAEUJERT-UHFFFAOYSA-N 344185 N-{4-[4-(3,3-dimethylbutanoyl)piperazin-1-yl]-2-methoxyphenyl}-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 79 High affinity nerve growth factor receptor Human 44.7 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344185 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344185&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252860 385450273 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679657 COc1cc(ccc1NC(=O)c1coc2CCNC(=O)c12)N1CCN(CC1)C(=O)N1CCCC1 InChI=1S/C24H29N5O5/c1-33-20-14-16(27-10-12-29(13-11-27)24(32)28-8-2-3-9-28)4-5-18(20)26-22(30)17-15-34-19-6-7-25-23(31)21(17)19/h4-5,14-15H,2-3,6-13H2,1H3,(H,25,31)(H,26,30) CDKOQXDAJQJMTG-UHFFFAOYSA-N 344186 N-{2-methoxy-4-[4-(pyrrolidin-1-ylcarbonyl)piperazin-1-yl]phenyl}-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 80 High affinity nerve growth factor receptor Human 67.7 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344186 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344186&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253060 385450274 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679658 COc1cc(ccc1NC(=O)c1coc2CCNC(=O)c12)N1CCN(CC1)S(=O)(=O)N(C)C InChI=1S/C21H27N5O6S/c1-24(2)33(29,30)26-10-8-25(9-11-26)14-4-5-16(18(12-14)31-3)23-20(27)15-13-32-17-6-7-22-21(28)19(15)17/h4-5,12-13H,6-11H2,1-3H3,(H,22,28)(H,23,27) SMDNZZWBDYLSQS-UHFFFAOYSA-N 344187 N-{4-[4-(dimethylsulfamoyl)piperazin-1-yl]-2-methoxyphenyl}-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 81 High affinity nerve growth factor receptor Human 65.8 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344187 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344187&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253071 385450275 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679659 COC(=O)c1ccc(Oc2nc(ccc2NC(=O)c2coc3CCCNC(=O)c23)N2CCN(C)CC2)cc1 InChI=1S/C27H29N5O6/c1-31-12-14-32(15-13-31)22-10-9-20(26(30-22)38-18-7-5-17(6-8-18)27(35)36-2)29-24(33)19-16-37-21-4-3-11-28-25(34)23(19)21/h5-10,16H,3-4,11-15H2,1-2H3,(H,28,34)(H,29,33) LLQCNJNUCIKWEO-UHFFFAOYSA-N 344188 US9777020, Example 82::methyl 4-{[6-(4-methylpiperazin-1-yl)-3-{[(4-oxo-5,6,7,8-tetrahydro-4H-furo[3,2-c]azepin-3-yl)carbonyl]amino}pyridin-2-yl]oxy}benzoate High affinity nerve growth factor receptor Human 682 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344188 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344188&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252974 385450276 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679660 CN1CCN(CC1)c1ccc(NC(=O)c2coc3CCCNC(=O)c23)c(Oc2ccc(CO)cc2)n1 InChI=1S/C26H29N5O5/c1-30-11-13-31(14-12-30)22-9-8-20(26(29-22)36-18-6-4-17(15-32)5-7-18)28-24(33)19-16-35-21-3-2-10-27-25(34)23(19)21/h4-9,16,32H,2-3,10-15H2,1H3,(H,27,34)(H,28,33) JUMIAELLGMWUEC-UHFFFAOYSA-N 344189 N-{2-[4-(hydroxymethyl)phenoxy]-6-(4-methylpiperazin-1-yl)pyridin-3-yl}-4-oxo-5,6,7,8-tetrahydro-4H-furo[3,2-c]azepine-3-carboxamide::US9777020, Example 83 High affinity nerve growth factor receptor Human 496 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344189 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344189&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252944 385450277 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679661 CCOc1nc(ccc1NC(=O)c1coc2CCN(CCOC)C(=O)c12)N1CCN(CC1)C(C)=O InChI=1S/C24H31N5O6/c1-4-34-23-18(5-6-20(26-23)28-11-9-27(10-12-28)16(2)30)25-22(31)17-15-35-19-7-8-29(13-14-33-3)24(32)21(17)19/h5-6,15H,4,7-14H2,1-3H3,(H,25,31) OQKGEQAFABBMFG-UHFFFAOYSA-N 344190 N-[6-(4-acetylpiperazin-1-yl)-2-ethoxypyridin-3-yl]-5-(2-methoxyethyl)-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 84 High affinity nerve growth factor receptor Human 5.30 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344190 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344190&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253034 385450278 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679662 COCCOc1nc(ccc1NC(=O)c1coc2CCN(CCOCc3ccccc3)C(=O)c12)N1CCN(CC1)C(C)=O InChI=1S/C31H37N5O7/c1-22(37)34-12-14-35(15-13-34)27-9-8-25(30(33-27)42-19-18-40-2)32-29(38)24-21-43-26-10-11-36(31(39)28(24)26)16-17-41-20-23-6-4-3-5-7-23/h3-9,21H,10-20H2,1-2H3,(H,32,38) CLPZDSMLPZLQCY-UHFFFAOYSA-N 344191 N-[6-(4-acetylpiperazin-1-yl)-2-(2-methoxyethoxyl)pyridin-3-yl]-5-[2-(benzyloxy)ethyl]-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 85 High affinity nerve growth factor receptor Human 266 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344191 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344191&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253111 385450279 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679663 CC(=O)N1CCN(CC1)c1ccc(NC(=O)c2coc3CCN(CCOCc4ccccc4)C(=O)c23)c(OCCOCc2ccccc2)n1 InChI=1S/C37H41N5O7/c1-27(43)40-16-18-41(19-17-40)33-13-12-31(36(39-33)48-23-22-47-25-29-10-6-3-7-11-29)38-35(44)30-26-49-32-14-15-42(37(45)34(30)32)20-21-46-24-28-8-4-2-5-9-28/h2-13,26H,14-25H2,1H3,(H,38,44) JUYVKDUHVRJWLN-UHFFFAOYSA-N 344192 N-{6-(4-acetylpiperazin-1-yl)-2-[2-(benzyloxy)ethoxy]pyridin-3-yl}-5-[2-(benzyloxy)ethyl]-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 86 High affinity nerve growth factor receptor Human 1320 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344192 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344192&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253175 385450280 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679664 COCCOc1nc(ccc1NC(=O)c1coc2CCN(CCO)C(=O)c12)N1CCN(CC1)C(C)=O InChI=1S/C24H31N5O7/c1-16(31)27-7-9-28(10-8-27)20-4-3-18(23(26-20)35-14-13-34-2)25-22(32)17-15-36-19-5-6-29(11-12-30)24(33)21(17)19/h3-4,15,30H,5-14H2,1-2H3,(H,25,32) PQRUIHMBZDGZMI-UHFFFAOYSA-N 344193 N-[6-(4-acetylpiperazin-1-yl)-2-(2-methoxyethoxyl)pyridin-3-yl]-5-(2-hydroxyethyl)-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 87 High affinity nerve growth factor receptor Human 224 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344193 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344193&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252968 385450281 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679665 CC(=O)N1CCN(CC1)c1ccc(NC(=O)c2coc3CCN(CCO)C(=O)c23)c(OCCO)n1 InChI=1S/C23H29N5O7/c1-15(31)26-6-8-27(9-7-26)19-3-2-17(22(25-19)34-13-12-30)24-21(32)16-14-35-18-4-5-28(10-11-29)23(33)20(16)18/h2-3,14,29-30H,4-13H2,1H3,(H,24,32) YPVLKNOLYFGQEL-UHFFFAOYSA-N 344194 N-[6-(4-acetylpiperazin-1-yl)-2-(2-hydroxyethoxyl)pyridin-3-yl]-5-(2-hydroxyethyl)-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 88 High affinity nerve growth factor receptor Human 95.0 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344194 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344194&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252810 385450282 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679666 CCOc1nc(ccc1NC(=O)c1coc2CCN(CCCO)C(=O)c12)N1CCN(CC1)C(C)=O InChI=1S/C24H31N5O6/c1-3-34-23-18(5-6-20(26-23)28-12-10-27(11-13-28)16(2)31)25-22(32)17-15-35-19-7-9-29(8-4-14-30)24(33)21(17)19/h5-6,15,30H,3-4,7-14H2,1-2H3,(H,25,32) ZNQUIQMMGKIFIO-UHFFFAOYSA-N 344195 N-[6-(4-acetylpiperazin-1-yl)-2-ethoxypyridin-3-yl]-5-(3-hydroxypropyl)-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 89 High affinity nerve growth factor receptor Human 4.70 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344195 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344195&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252943 385450283 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679667 CCOc1nc(ccc1NC(=O)c1coc2CCN(CCCCO)C(=O)c12)N1CCN(CC1)C(C)=O InChI=1S/C25H33N5O6/c1-3-35-24-19(6-7-21(27-24)29-13-11-28(12-14-29)17(2)32)26-23(33)18-16-36-20-8-10-30(9-4-5-15-31)25(34)22(18)20/h6-7,16,31H,3-5,8-15H2,1-2H3,(H,26,33) VOLKTNMKVIPUSL-UHFFFAOYSA-N 344196 N-[6-(4-acetylpiperazin-1-yl)-2-ethoxypyridin-3-yl]-5-(4-hydroxybutyl)-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 90 High affinity nerve growth factor receptor Human 4.70 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344196 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344196&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252916 385450284 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679668 CCOc1nc(ccc1NC(=O)c1coc2CCN(CCOCCO)C(=O)c12)N1CCN(CC1)C(C)=O InChI=1S/C25H33N5O7/c1-3-36-24-19(4-5-21(27-24)29-10-8-28(9-11-29)17(2)32)26-23(33)18-16-37-20-6-7-30(25(34)22(18)20)12-14-35-15-13-31/h4-5,16,31H,3,6-15H2,1-2H3,(H,26,33) VVADLKUCNLCCHH-UHFFFAOYSA-N 344197 N-[6-(4-acetylpiperazin-1-yl)-2-ethoxypyridin-3-yl]-5-[2-(2-hydroxyethoxyl)ethyl]-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 91 High affinity nerve growth factor receptor Human 7.00 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344197 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344197&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253066 385450285 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679669 CCOc1nc(ccc1NC(=O)c1coc2CCNC(=O)c12)N1CCN(CC1)C(=O)OC(C)(C)C InChI=1S/C24H31N5O6/c1-5-33-22-16(26-20(30)15-14-34-17-8-9-25-21(31)19(15)17)6-7-18(27-22)28-10-12-29(13-11-28)23(32)35-24(2,3)4/h6-7,14H,5,8-13H2,1-4H3,(H,25,31)(H,26,30) PMJCLQDOLDRKIC-UHFFFAOYSA-N 344198 US9777020, Example 92::tert-butyl 4-(6-ethoxy-5-{[(4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridin-3-yl)carbonyl]amino}pyridin-2-yl)piperazine-1-carboxylate High affinity nerve growth factor receptor Human 18.2 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344198 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344198&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252836 385450286 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679670 CCOc1nc(ccc1NC(=O)c1coc2CCNC(=O)c12)N1CCN(CC1)C(NC)=NC#N InChI=1S/C22H26N8O4/c1-3-33-21-15(27-19(31)14-12-34-16-6-7-25-20(32)18(14)16)4-5-17(28-21)29-8-10-30(11-9-29)22(24-2)26-13-23/h4-5,12H,3,6-11H2,1-2H3,(H,24,26)(H,25,32)(H,27,31) KGQYFQSISGZACD-UHFFFAOYSA-N 344199 N-{6-[4-(N′-cyano-N-methylcarbamimidoyl)piperazin-1-yl]-2-ethoxypyridin-3-yl}-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 93 High affinity nerve growth factor receptor Human 16.3 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344199 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344199&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252769 385450287 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679671 CCOc1nc(ccc1NC(=O)c1coc2CCN(C[C@@H](C)OC(C)=O)C(=O)c12)N1CCN(CC1)C(C)=O InChI=1S/C26H33N5O7/c1-5-36-25-20(6-7-22(28-25)30-12-10-29(11-13-30)17(3)32)27-24(34)19-15-37-21-8-9-31(26(35)23(19)21)14-16(2)38-18(4)33/h6-7,15-16H,5,8-14H2,1-4H3,(H,27,34)/t16-/m1/s1 ADTXOJBXMSVFPB-MRXNPFEDSA-N 344200 (2R)-1-[3-{[6-(4-acetylpiperazin-1-yl)-2-ethoxypyridin-3-yl]carbamoyl}-4-oxo-6,7-dihydrofuro[3,2-c]pyridin-5(4H)-yl]propan-2-yl acetate::US9777020, Example 94 High affinity nerve growth factor receptor Human 1.50 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344200 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344200&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252813 385450288 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679672 CCOc1nc(ccc1NC(=O)c1coc2CCN(C[C@@H](C)O)C(=O)c12)N1CCN(CC1)C(C)=O InChI=1S/C24H31N5O6/c1-4-34-23-18(5-6-20(26-23)28-11-9-27(10-12-28)16(3)31)25-22(32)17-14-35-19-7-8-29(13-15(2)30)24(33)21(17)19/h5-6,14-15,30H,4,7-13H2,1-3H3,(H,25,32)/t15-/m1/s1 XSOVLIBJOPNJAI-OAHLLOKOSA-N 344201 N-[6-(4-acetylpiperazin-1-yl)-2-ethoxypyridin-3-yl]-5-[(2R)-2-hydroxypropyl]-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 95 High affinity nerve growth factor receptor Human 4.30 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344201 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344201&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252875 385450289 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679673 CCOc1nc(ccc1NC(=O)c1coc2CCN(C[C@H](C)OC(C)=O)C(=O)c12)N1CCN(CC1)C(C)=O InChI=1S/C26H33N5O7/c1-5-36-25-20(6-7-22(28-25)30-12-10-29(11-13-30)17(3)32)27-24(34)19-15-37-21-8-9-31(26(35)23(19)21)14-16(2)38-18(4)33/h6-7,15-16H,5,8-14H2,1-4H3,(H,27,34)/t16-/m0/s1 ADTXOJBXMSVFPB-INIZCTEOSA-N 344202 (2S)-1-[3-{[6-(4-acetylpiperazin-1-yl)-2-ethoxypyridin-3-yl]carbamoyl}-4-oxo-6,7-dihydrofuro[3,2-c]pyridin-5(4H)-yl]propan-2-yl acetate::US9777020, Example 96 High affinity nerve growth factor receptor Human 6.70 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344202 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344202&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252827 385450290 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679674 CCOc1nc(ccc1NC(=O)c1coc2CCN(C[C@H](C)O)C(=O)c12)N1CCN(CC1)C(C)=O InChI=1S/C24H31N5O6/c1-4-34-23-18(5-6-20(26-23)28-11-9-27(10-12-28)16(3)31)25-22(32)17-14-35-19-7-8-29(13-15(2)30)24(33)21(17)19/h5-6,14-15,30H,4,7-13H2,1-3H3,(H,25,32)/t15-/m0/s1 XSOVLIBJOPNJAI-HNNXBMFYSA-N 344203 N-[6-(4-acetylpiperazin-1-yl)-2-ethoxypyridin-3-yl]-5-[(2S)-2-hydroxypropyl]-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 97 High affinity nerve growth factor receptor Human 4.80 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344203 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344203&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253048 385450291 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679675 CCOc1nc(ccc1NC(=O)c1coc2CCN([C@H](C)COC(C)=O)C(=O)c12)N1CCN(CC1)C(C)=O InChI=1S/C26H33N5O7/c1-5-36-25-20(6-7-22(28-25)30-12-10-29(11-13-30)17(3)32)27-24(34)19-15-38-21-8-9-31(26(35)23(19)21)16(2)14-37-18(4)33/h6-7,15-16H,5,8-14H2,1-4H3,(H,27,34)/t16-/m1/s1 XEDUTMAWRFIXCW-MRXNPFEDSA-N 344204 (2R)-2-[3-{[6-(4-acetylpiperazin-1-yl)-2-ethoxypyridin-3-yl]carbamoyl}-4-oxo-6,7-dihydrofuro[3,2-c]pyridin-5(4H)-yl]propyl acetate::US9777020, Example 98 High affinity nerve growth factor receptor Human 1.50 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344204 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344204&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253026 385450292 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679676 CCOc1nc(ccc1NC(=O)c1coc2CCN([C@H](C)CO)C(=O)c12)N1CCN(CC1)C(C)=O InChI=1S/C24H31N5O6/c1-4-34-23-18(5-6-20(26-23)28-11-9-27(10-12-28)16(3)31)25-22(32)17-14-35-19-7-8-29(15(2)13-30)24(33)21(17)19/h5-6,14-15,30H,4,7-13H2,1-3H3,(H,25,32)/t15-/m1/s1 IQJLPLLZRSTGBO-OAHLLOKOSA-N 344205 N-[6-(4-acetylpiperazin-1-yl)-2-ethoxypyridin-3-yl]-5-[(2R)-1-hydroxypropan-2-yl]-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 99 High affinity nerve growth factor receptor Human 3.30 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344205 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344205&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252965 385450293 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679677 CCOc1nc(ccc1NC(=O)c1coc2CCN([C@@H](C)COC(C)=O)C(=O)c12)N1CCN(CC1)C(C)=O InChI=1S/C26H33N5O7/c1-5-36-25-20(6-7-22(28-25)30-12-10-29(11-13-30)17(3)32)27-24(34)19-15-38-21-8-9-31(26(35)23(19)21)16(2)14-37-18(4)33/h6-7,15-16H,5,8-14H2,1-4H3,(H,27,34)/t16-/m0/s1 XEDUTMAWRFIXCW-INIZCTEOSA-N 344206 (2S)-2-[3-{[6-(4-acetylpiperazin-1-yl)-2-ethoxypyridin-3-yl]carbamoyl}-4-oxo-6,7-dihydrofuro[3,2-c]pyridin-5(4H)-yl]propyl acetate::US9777020, Example 100 High affinity nerve growth factor receptor Human 23.5 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344206 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344206&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252933 385450294 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679678 CCOc1nc(ccc1NC(=O)c1coc2CCN([C@@H](C)CO)C(=O)c12)N1CCN(CC1)C(C)=O InChI=1S/C24H31N5O6/c1-4-34-23-18(5-6-20(26-23)28-11-9-27(10-12-28)16(3)31)25-22(32)17-14-35-19-7-8-29(15(2)13-30)24(33)21(17)19/h5-6,14-15,30H,4,7-13H2,1-3H3,(H,25,32)/t15-/m0/s1 IQJLPLLZRSTGBO-HNNXBMFYSA-N 344207 N-[6-(4-acetylpiperazin-1-yl)-2-ethoxypyridin-3-yl]-5-[(2S)-1-hydroxypropan-2-yl]-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 101 High affinity nerve growth factor receptor Human 19.5 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344207 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344207&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252831 385450295 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679679 CCOc1nc(ccc1NC(=O)c1coc2CCN(C(=O)c12)C(C)(C)CO)N1CCN(CC1)C(C)=O InChI=1S/C25H33N5O6/c1-5-35-23-18(6-7-20(27-23)29-12-10-28(11-13-29)16(2)32)26-22(33)17-14-36-19-8-9-30(24(34)21(17)19)25(3,4)15-31/h6-7,14,31H,5,8-13,15H2,1-4H3,(H,26,33) MPQRVELBLFLFSC-UHFFFAOYSA-N 344208 N-[6-(4-acetylpiperazin-1-yl)-2-ethoxypyridin-3-yl]-5-(1-hydroxy-2-methylpropan-2-yl)-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 102 High affinity nerve growth factor receptor Human 12.7 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344208 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344208&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253010 385450296 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679680 CCOc1nc(ccc1NC(=O)c1coc2CCN(CC(C)(C)OC(C)=O)C(=O)c12)N1CCN(CC1)C(C)=O InChI=1S/C27H35N5O7/c1-6-37-25-20(7-8-22(29-25)31-13-11-30(12-14-31)17(2)33)28-24(35)19-15-38-21-9-10-32(26(36)23(19)21)16-27(4,5)39-18(3)34/h7-8,15H,6,9-14,16H2,1-5H3,(H,28,35) SVXLLGYONUDZMF-UHFFFAOYSA-N 344209 1-[3-{[6-(4-acetylpiperazin-1-yl)-2-ethoxypyridin-3-yl]carbamoyl}-4-oxo-6,7-dihydrofuro[3,2-c]pyridin-5(4H)-yl]-2-methylpropan-2-yl acetate::US9777020, Example 103 High affinity nerve growth factor receptor Human 16.9 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344209 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344209&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253046 385450297 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679681 CCOc1nc(ccc1NC(=O)c1coc2CCN(CC(C)(C)O)C(=O)c12)N1CCN(CC1)C(C)=O InChI=1S/C25H33N5O6/c1-5-35-23-18(6-7-20(27-23)29-12-10-28(11-13-29)16(2)31)26-22(32)17-14-36-19-8-9-30(15-25(3,4)34)24(33)21(17)19/h6-7,14,34H,5,8-13,15H2,1-4H3,(H,26,32) KXTDQUGWQWCUFF-UHFFFAOYSA-N 344210 N-[6-(4-acetylpiperazin-1-yl)-2-ethoxypyridin-3-yl]-5-(2-hydroxy-2-methylpropyl)-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 104 High affinity nerve growth factor receptor Human 6.00 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344210 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344210&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253139 385450298 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679682 CC(=O)N1CCN(CC1)c1ccc(NC(=O)c2coc3CCNC(=O)c23)c(O[C@H]2CCOC2)n1 InChI=1S/C23H27N5O6/c1-14(29)27-7-9-28(10-8-27)19-3-2-17(23(26-19)34-15-5-11-32-12-15)25-21(30)16-13-33-18-4-6-24-22(31)20(16)18/h2-3,13,15H,4-12H2,1H3,(H,24,31)(H,25,30)/t15-/m0/s1 CANYPHAXSOWVNR-HNNXBMFYSA-N 344211 N-{6-(4-acetylpiperazin-1-yl)-2-[(3S)-tetrahydrofuran-3-yloxy]pyridin-3-yl}-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 105 High affinity nerve growth factor receptor Human 23.5 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344211 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344211&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253121 385450299 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679683 CCOc1nc(ccc1NC(=O)c1coc2CCNC(=O)c12)N1CCOCC1 InChI=1S/C19H22N4O5/c1-2-27-19-13(3-4-15(22-19)23-7-9-26-10-8-23)21-17(24)12-11-28-14-5-6-20-18(25)16(12)14/h3-4,11H,2,5-10H2,1H3,(H,20,25)(H,21,24) CTFXMRGJVSWVTH-UHFFFAOYSA-N 344212 N-[2-ethoxy-6-(morpholin-4-yl)pyridin-3-yl]-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 106 High affinity nerve growth factor receptor Human 28.6 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344212 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344212&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253090 385450300 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679684 CC(C)(O)COc1nc(ccc1NC(=O)c1coc2CCNC(=O)c12)N1CCOCC1 InChI=1S/C21H26N4O6/c1-21(2,28)12-31-20-14(3-4-16(24-20)25-7-9-29-10-8-25)23-18(26)13-11-30-15-5-6-22-19(27)17(13)15/h3-4,11,28H,5-10,12H2,1-2H3,(H,22,27)(H,23,26) HPCLQWFLOFTYKL-UHFFFAOYSA-N 344213 N-[2-(2-hydroxy-2-methylpropoxy)-6-(morpholin-4-yl)pyridin-3-yl]-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 107 High affinity nerve growth factor receptor Human 6.90 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344213 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344213&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252981 385450301 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679685 CCOc1nc(CC(=O)OC)ccc1NC(=O)c1coc2CCNC(=O)c12 InChI=1S/C18H19N3O6/c1-3-26-18-12(5-4-10(20-18)8-14(22)25-2)21-16(23)11-9-27-13-6-7-19-17(24)15(11)13/h4-5,9H,3,6-8H2,1-2H3,(H,19,24)(H,21,23) OZOPGERHJKIPQJ-UHFFFAOYSA-N 344214 US9777020, Example 108::methyl(6-ethoxy-5-{[(4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridin-3-yl)carbonyl]amino}pyridin-2-yl)acetate High affinity nerve growth factor receptor Human 226 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344214 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344214&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 131743241 385450302 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679686 CCOc1nc(CCO)ccc1NC(=O)c1coc2CCNC(=O)c12 InChI=1S/C17H19N3O5/c1-2-24-17-12(4-3-10(19-17)6-8-21)20-15(22)11-9-25-13-5-7-18-16(23)14(11)13/h3-4,9,21H,2,5-8H2,1H3,(H,18,23)(H,20,22) RHCIFNSHHPRPLM-UHFFFAOYSA-N 344215 N-[2-ethoxy-6-(2-hydroxyethyl)pyridin-3-yl]-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 109 High affinity nerve growth factor receptor Human 225 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344215 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344215&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252997 385450303 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679687 COc1nc(ccc1NC(=O)c1coc2CC3(CCOCC3)CC(=O)c12)N1CCN(CC1)C(C)=O InChI=1S/C25H30N4O6/c1-16(30)28-7-9-29(10-8-28)21-4-3-18(24(27-21)33-2)26-23(32)17-15-35-20-14-25(5-11-34-12-6-25)13-19(31)22(17)20/h3-4,15H,5-14H2,1-2H3,(H,26,32) FBPKVJBASQABSE-UHFFFAOYSA-N 344216 N-[6-(4-acetylpiperazin-1-yl)-2-methoxypyridin-3-yl]-4-oxo-2′,3′,4,5′,6′,7-hexahydro-5H-spiro[1-benzofuran-6,4′-pyran]-3-carboxamide::US9777020, Example 110 High affinity nerve growth factor receptor Human 39.2 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344216 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344216&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252989 385450304 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679688 CCOc1nc(ccc1NC(=O)c1coc2CC3(CCC3)NC(=O)c12)N1CCN(CC1)C(C)=O InChI=1S/C24H29N5O5/c1-3-33-23-17(5-6-19(26-23)29-11-9-28(10-12-29)15(2)30)25-21(31)16-14-34-18-13-24(7-4-8-24)27-22(32)20(16)18/h5-6,14H,3-4,7-13H2,1-2H3,(H,25,31)(H,27,32) IUDXHZMYWRINGG-UHFFFAOYSA-N 344217 N-[6-(4-acetylpiperazin-1-yl)-2-ethoxypyridin-3-yl]-4′-oxo-4′,7′-dihydro-5′H-spiro[cyclobutane-1,6′-furo[3,2-c]pyridine]-3′-carboxamide::US9777020, Example 111 High affinity nerve growth factor receptor Human 3.90 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344217 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344217&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253007 385450305 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679689 CCOc1nc(ccc1NC(=O)c1coc2CC3(CCCCC3)NC(=O)c12)N1CCN(CC1)C(C)=O InChI=1S/C26H33N5O5/c1-3-35-25-19(7-8-21(28-25)31-13-11-30(12-14-31)17(2)32)27-23(33)18-16-36-20-15-26(9-5-4-6-10-26)29-24(34)22(18)20/h7-8,16H,3-6,9-15H2,1-2H3,(H,27,33)(H,29,34) BUBUEOOSXDFBCM-UHFFFAOYSA-N 344218 N-[6-(4-acetylpiperazin-1-yl)-2-ethoxypyridin-3-yl]-4′-oxo-4′,7′-dihydro-5′H-spiro[cyclohexane-1,6′-furo[3,2-c]pyridine]-3′-carboxamide::US9777020, Example 112 High affinity nerve growth factor receptor Human 27.3 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344218 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344218&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252896 385450306 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679690 CCOc1nc(ccc1NC(=O)c1coc2CC3(CN(C3)C(C)=O)NC(=O)c12)N1CCN(CC1)C(C)=O InChI=1S/C25H30N6O6/c1-4-36-24-18(5-6-20(27-24)30-9-7-29(8-10-30)15(2)32)26-22(34)17-12-37-19-11-25(28-23(35)21(17)19)13-31(14-25)16(3)33/h5-6,12H,4,7-11,13-14H2,1-3H3,(H,26,34)(H,28,35) SIHDNUDPWCWHIB-UHFFFAOYSA-N 344219 1-acetyl-N-[6-(4-acetylpiperazin-1-yl)-2-ethoxypyridin-3-yl]-4′-oxo-4′,7′-dihydro-5′H-spiro[azetidine-3,6′-furo[3,2-c]pyridine]-3′-carboxamide::US9777020, Example 113 High affinity nerve growth factor receptor Human 65.4 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344219 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344219&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252856 385450307 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679691 CCOc1nc(ccc1NC(=O)c1coc2CC3(COC3)NC(=O)c12)N1CCN(CC1)C(C)=O InChI=1S/C23H27N5O6/c1-3-33-22-16(4-5-18(25-22)28-8-6-27(7-9-28)14(2)29)24-20(30)15-11-34-17-10-23(12-32-13-23)26-21(31)19(15)17/h4-5,11H,3,6-10,12-13H2,1-2H3,(H,24,30)(H,26,31) FMGCYEGSXBFTIV-UHFFFAOYSA-N 344220 N-[6-(4-acetylpiperazin-1-yl)-2-ethoxypyridin-3-yl]-4-oxo-4,7-dihydro-5H-spiro[furo[3,2-c]pyridine-6,3′-oxetane]-3-carboxamide::US9777020, Example 114 High affinity nerve growth factor receptor Human 7.20 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344220 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344220&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253003 385450308 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679692 CCOc1nc(ccc1NC(=O)c1coc2C[C@@H](NC(=O)c12)[C@@H](C)O)N1CCN(CC1)C(C)=O InChI=1S/C23H29N5O6/c1-4-33-23-16(5-6-19(26-23)28-9-7-27(8-10-28)14(3)30)24-21(31)15-12-34-18-11-17(13(2)29)25-22(32)20(15)18/h5-6,12-13,17,29H,4,7-11H2,1-3H3,(H,24,31)(H,25,32)/t13-,17-/m1/s1 UULIMWJTEWYQLB-CXAGYDPISA-N 344221 (6R)¿N-[6-(4-acetylpiperazin-1-yl)-2-ethoxypyridin-3-yl]-6-[(1R)-1-hydroxyethyl]-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 115 High affinity nerve growth factor receptor Human 8.50 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344221 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344221&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252928 385450309 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679693 CCOc1nc(ccc1NC(=O)c1coc2CC3(CCC3)N(CCO)C(=O)c12)N1CCN(CC1)C(C)=O InChI=1S/C26H33N5O6/c1-3-36-24-19(5-6-21(28-24)30-11-9-29(10-12-30)17(2)33)27-23(34)18-16-37-20-15-26(7-4-8-26)31(13-14-32)25(35)22(18)20/h5-6,16,32H,3-4,7-15H2,1-2H3,(H,27,34) OVTVBJHVODXZBT-UHFFFAOYSA-N 344222 N-[6-(4-acetylpiperazin-1-yl)-2-ethoxypyridin-3-yl]-5′-(2-hydroxyethyl)-4′-oxo-4′,7′-dihydro-5′H-spiro[cyclobutane-1,6′-furo[3,2-c]pyridine]-3′-carboxamide::US9777020, Example 116 High affinity nerve growth factor receptor Human 3.10 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344222 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344222&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252951 385450310 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679694 CCOc1nc(ccc1NC(=O)c1coc2CC3(CC3)NC(=O)c12)N1CCN(CC1)C(C)=O InChI=1S/C23H27N5O5/c1-3-32-22-16(4-5-18(25-22)28-10-8-27(9-11-28)14(2)29)24-20(30)15-13-33-17-12-23(6-7-23)26-21(31)19(15)17/h4-5,13H,3,6-12H2,1-2H3,(H,24,30)(H,26,31) ATTULPGCYSBHSR-UHFFFAOYSA-N 344223 N-[6-(4-acetylpiperazin-1-yl)-2-ethoxypyridin-3-yl]-4′-oxo-4′,7′-dihydro-5′H-spiro[cyclopropane-1,6′-furo[3,2-c]pyridine]-3′-carboxamide::US9777020, Example 117 High affinity nerve growth factor receptor Human 5.30 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344223 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344223&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252956 385450311 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679695 CCOc1nc(ccc1NC(=O)c1coc2CC3(CCC3)NC(=O)c12)N1CCN(CC1)C(NC)=NC#N InChI=1S/C25H30N8O4/c1-3-36-23-17(5-6-19(30-23)32-9-11-33(12-10-32)24(27-2)28-15-26)29-21(34)16-14-37-18-13-25(7-4-8-25)31-22(35)20(16)18/h5-6,14H,3-4,7-13H2,1-2H3,(H,27,28)(H,29,34)(H,31,35) BRWNKESNHWTGEB-UHFFFAOYSA-N 344224 N-{6-[4-(N′-cyano-N-methylcarbamimidoyl)piperazin-1-yl]-2-ethoxypyridin-3-yl}-4′-oxo-4′,7′-dihydro-5′H-spiro[cyclobutane-1,6′-furo[3,2-c]pyridine]-3′-carboxamide::US9777020, Example 118 High affinity nerve growth factor receptor Human 3.00 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344224 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344224&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252995 385450312 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679696 CCOc1nc(ccc1NC(=O)c1coc2CC(C)(C)N(CC(O)CO)C(=O)c12)N1CCN(CC1)C(C)=O InChI=1S/C26H35N5O7/c1-5-37-24-19(6-7-21(28-24)30-10-8-29(9-11-30)16(2)33)27-23(35)18-15-38-20-12-26(3,4)31(13-17(34)14-32)25(36)22(18)20/h6-7,15,17,32,34H,5,8-14H2,1-4H3,(H,27,35) FJVMONYBJBIHCN-UHFFFAOYSA-N 344225 N-[6-(4-acetylpiperazin-1-yl)-2-ethoxypyridin-3-yl]-5-(2,3-dihydroxypropyl)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 119 High affinity nerve growth factor receptor Human 6.80 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344225 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344225&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252782 385450313 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679697 COc1cc(ccc1NC(=O)c1coc2CC(C)(C)NC(=O)c12)N1CCNCC1 InChI=1S/C21H26N4O4/c1-21(2)11-17-18(20(27)24-21)14(12-29-17)19(26)23-15-5-4-13(10-16(15)28-3)25-8-6-22-7-9-25/h4-5,10,12,22H,6-9,11H2,1-3H3,(H,23,26)(H,24,27) WQYJZLRUTORTNF-UHFFFAOYSA-N 344226 N-[2-methoxy-4-(piperazin-1-yl)phenyl]-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 120 High affinity nerve growth factor receptor Human 28.0 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344226 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344226&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253073 385450314 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679698 COc1nc(ccc1NC(=O)c1coc2CC(C)(C)NC(=O)c12)N1CCN(CC1)C(=O)N1CCOCC1 InChI=1S/C25H32N6O6/c1-25(2)14-18-20(22(33)28-25)16(15-37-18)21(32)26-17-4-5-19(27-23(17)35-3)29-6-8-30(9-7-29)24(34)31-10-12-36-13-11-31/h4-5,15H,6-14H2,1-3H3,(H,26,32)(H,28,33) ZXEXNCWNAOVZTG-UHFFFAOYSA-N 344227 N-{2-methoxy-6-[4-(morpholin-4-ylcarbonyl)piperazin-1-yl]pyridin-3-yl}-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 121 High affinity nerve growth factor receptor Human 18.1 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344227 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344227&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 91826222 385450315 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679699 COc1nc(ccc1NC(=O)c1coc2CC(C)(C)NC(=O)c12)N1CCN(CC1)C(C)=O InChI=1S/C22H27N5O5/c1-13(28)26-7-9-27(10-8-26)17-6-5-15(21(24-17)31-4)23-19(29)14-12-32-16-11-22(2,3)25-20(30)18(14)16/h5-6,12H,7-11H2,1-4H3,(H,23,29)(H,25,30) MAYVJKHAVPWRIT-UHFFFAOYSA-N 344228 N-[6-(4-acetylpiperazin-1-yl)-2-methoxypyridin-3-yl]-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 122 High affinity nerve growth factor receptor Human 14.1 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344228 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344228&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252824 385450316 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679700 COc1nc(ccc1NC(=O)c1coc2CC(C)(C)NC(=O)c12)N1CCN(CC1)C(=O)N1CCCC1 InChI=1S/C25H32N6O5/c1-25(2)14-18-20(22(33)28-25)16(15-36-18)21(32)26-17-6-7-19(27-23(17)35-3)29-10-12-31(13-11-29)24(34)30-8-4-5-9-30/h6-7,15H,4-5,8-14H2,1-3H3,(H,26,32)(H,28,33) WRWDSPZTXOPSCI-UHFFFAOYSA-N 344229 N-{2-methoxy-6-[4-(pyrrolidin-1-ylcarbonyl)piperazin-1-yl]pyridin-3-yl}-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 123 High affinity nerve growth factor receptor Human 11.9 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344229 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344229&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253038 385450317 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679701 COc1cc(ccc1NC(=O)c1coc2CC(C)NC(=O)c12)N1CCNCC1 InChI=1S/C20H24N4O4/c1-12-9-17-18(20(26)22-12)14(11-28-17)19(25)23-15-4-3-13(10-16(15)27-2)24-7-5-21-6-8-24/h3-4,10-12,21H,5-9H2,1-2H3,(H,22,26)(H,23,25) MEGRTROGFFBRJV-UHFFFAOYSA-N 344230 N-[2-methoxy-4-(piperazin-1-yl)phenyl]-6-methyl-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 124 High affinity nerve growth factor receptor Human 73.7 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344230 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344230&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252825 385450318 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679702 COc1cc(ccc1NC(=O)c1coc2CC(C)(C)NC(=O)c12)N1CCN(CC1)S(C)(=O)=O InChI=1S/C22H28N4O6S/c1-22(2)12-18-19(21(28)24-22)15(13-32-18)20(27)23-16-6-5-14(11-17(16)31-3)25-7-9-26(10-8-25)33(4,29)30/h5-6,11,13H,7-10,12H2,1-4H3,(H,23,27)(H,24,28) SLFACYDQMBSCMP-UHFFFAOYSA-N 344231 N-{2-methoxy-4-[4-(methylsulfonyl)piperazin-1-yl]phenyl}-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 125 High affinity nerve growth factor receptor Human 35.9 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344231 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344231&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253062 385450319 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679703 COc1cc(ccc1NC(=O)c1coc2CC(C)(C)NC(=O)c12)N1CCN(CC1)C(C)=O InChI=1S/C23H28N4O5/c1-14(28)26-7-9-27(10-8-26)15-5-6-17(18(11-15)31-4)24-21(29)16-13-32-19-12-23(2,3)25-22(30)20(16)19/h5-6,11,13H,7-10,12H2,1-4H3,(H,24,29)(H,25,30) VYXDWWIVSIBUDC-UHFFFAOYSA-N 344232 N-[4-(4-acetylpiperazin-1-yl)-2-methoxyphenyl]-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 126 High affinity nerve growth factor receptor Human 25.0 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344232 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344232&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253025 385450320 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679704 CCOc1nc(ccc1NC(=O)c1coc2CC(C)(C)NC(=O)c12)N1CCNCC1 InChI=1S/C21H27N5O4/c1-4-29-20-14(5-6-16(24-20)26-9-7-22-8-10-26)23-18(27)13-12-30-15-11-21(2,3)25-19(28)17(13)15/h5-6,12,22H,4,7-11H2,1-3H3,(H,23,27)(H,25,28) LZNISVUAJYHFLP-UHFFFAOYSA-N 344233 N-[2-ethoxy-6-(piperazin-1-yl)pyridin-3-yl]-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 127 High affinity nerve growth factor receptor Human 13.2 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344233 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344233&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253050 385450321 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679705 CCOc1nc(ccc1NC(=O)c1coc2CC(C)(C)NC(=O)c12)N1CCN(CC1)C(C)=O InChI=1S/C23H29N5O5/c1-5-32-22-16(6-7-18(25-22)28-10-8-27(9-11-28)14(2)29)24-20(30)15-13-33-17-12-23(3,4)26-21(31)19(15)17/h6-7,13H,5,8-12H2,1-4H3,(H,24,30)(H,26,31) CSJGDVDHGSDWIV-UHFFFAOYSA-N 344234 N-[6-(4-acetylpiperazin-1-yl)-2-ethoxypyridin-3-yl]-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 128 High affinity nerve growth factor receptor Human 5.40 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344234 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344234&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253098 385450322 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679706 CC(C)Oc1nc(ccc1NC(=O)c1coc2CC(C)(C)NC(=O)c12)N1C[C@H]2CCN[C@H]2C1 InChI=1S/C24H31N5O4/c1-13(2)33-23-16(5-6-19(27-23)29-10-14-7-8-25-17(14)11-29)26-21(30)15-12-32-18-9-24(3,4)28-22(31)20(15)18/h5-6,12-14,17,25H,7-11H2,1-4H3,(H,26,30)(H,28,31)/t14-,17+/m1/s1 GQXSTFVHKVEKBK-PBHICJAKSA-N 344235 N-{6-[(3 aR,6aR)-hexahydropyrrolo[3,4-b]pyrrol-5(1H)-yl]-2-isopropoxypyridin-3-yl}-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 129 High affinity nerve growth factor receptor Human 10.8 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344235 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344235&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253052 385450323 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679707 COc1nc(ccc1NC(=O)c1coc2CC(C)(C)NC(=O)c12)N1CC[C@@H]2CN(C)C[C@H]12 InChI=1S/C23H29N5O4/c1-23(2)9-17-19(21(30)26-23)14(12-32-17)20(29)24-15-5-6-18(25-22(15)31-4)28-8-7-13-10-27(3)11-16(13)28/h5-6,12-13,16H,7-11H2,1-4H3,(H,24,29)(H,26,30)/t13-,16+/m1/s1 AOEFWFMRGCUXTR-CJNGLKHVSA-N 344236 N-{2-methoxy-6-[(3aR,6aR)-5-methylhexahydropyrrolo[3,4-b]pyrrol-1 (2H)-yl]pyridin-3-yl}-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 130 High affinity nerve growth factor receptor Human 38.3 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344236 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344236&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252802 385450324 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679708 CC(C)Oc1nc(ccc1NC(=O)c1coc2CC(C)(C)NC(=O)c12)N1C[C@@H]2CCN(CCO)[C@@H]2C1 InChI=1S/C26H35N5O5/c1-15(2)36-25-18(27-23(33)17-14-35-20-11-26(3,4)29-24(34)22(17)20)5-6-21(28-25)31-12-16-7-8-30(9-10-32)19(16)13-31/h5-6,14-16,19,32H,7-13H2,1-4H3,(H,27,33)(H,29,34)/t16-,19+/m0/s1 CTGVXVRPQWBNSW-QFBILLFUSA-N 344237 N-{6-[(3aS,6aS)-1-(2-hydroxyethyl)hexahydropyrrolo[3,4-b]pyrrol-5(1H)-yl]-2-isopropoxypyridin-3-yl}-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 131 High affinity nerve growth factor receptor Human 98.1 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344237 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344237&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253033 385450325 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679709 CC(C)Oc1nc(ccc1NC(=O)c1coc2CC(C)(C)NC(=O)c12)N1C[C@H]2CCN([C@H]2C1)C(=O)N1CCN(C)CC1 InChI=1S/C30H41N7O5/c1-18(2)42-28-21(31-26(38)20-17-41-23-14-30(3,4)33-27(39)25(20)23)6-7-24(32-28)36-15-19-8-9-37(22(19)16-36)29(40)35-12-10-34(5)11-13-35/h6-7,17-19,22H,8-16H2,1-5H3,(H,31,38)(H,33,39)/t19-,22+/m1/s1 YWJOOGJCTHPTQF-KNQAVFIVSA-N 344238 N-{2-isopropoxy-6-[(3aR,6aR)-1-[(4-methylpiperazin-1-yl)carbonyl]hexahydropyrrolo[3,4-b]pyrrol-5(1H)-yl]pyridin-3-yl}-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 132 High affinity nerve growth factor receptor Human 6.90 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344238 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344238&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253084 385450326 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679710 CC(C)Oc1nc(ccc1NC(=O)c1coc2CC(C)(C)NC(=O)c12)N1CCN([C@H](CO)C1)C(C)=O InChI=1S/C25H33N5O6/c1-14(2)36-24-18(6-7-20(27-24)29-8-9-30(15(3)32)16(11-29)12-31)26-22(33)17-13-35-19-10-25(4,5)28-23(34)21(17)19/h6-7,13-14,16,31H,8-12H2,1-5H3,(H,26,33)(H,28,34)/t16-/m0/s1 XLOCJNRLTQQVSJ-INIZCTEOSA-N 344239 N-{6-[(3S)-4-acetyl-3-(hydroxymethyl)piperazin-1-yl]-2-isopropoxypyridin-3-yl}-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 133 High affinity nerve growth factor receptor Human 3.30 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344239 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344239&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253152 385450327 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679711 CC(C)Oc1nc(ccc1NC(=O)c1coc2CC(C)(C)NC(=O)c12)N1CCN(C[C@H]1CO)C(C)=O InChI=1S/C25H33N5O6/c1-14(2)36-24-18(6-7-20(27-24)30-9-8-29(15(3)32)11-16(30)12-31)26-22(33)17-13-35-19-10-25(4,5)28-23(34)21(17)19/h6-7,13-14,16,31H,8-12H2,1-5H3,(H,26,33)(H,28,34)/t16-/m0/s1 WNTJSUYENUORNM-INIZCTEOSA-N 344240 N-{6-[(2S)-4-acetyl-2-(hydroxymethyl)piperazin-1-yl]-2-isopropoxypyridin-3-yl}-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 134 High affinity nerve growth factor receptor Human 3.90 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344240 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344240&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252845 385450328 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679712 CC(C)Oc1nc(ccc1NC(=O)c1coc2CC(C)(C)NC(=O)c12)N1CCN(C[C@H]1CO)C(=O)N1CCOCC1 InChI=1S/C28H38N6O7/c1-17(2)41-26-20(29-24(36)19-16-40-21-13-28(3,4)31-25(37)23(19)21)5-6-22(30-26)34-8-7-33(14-18(34)15-35)27(38)32-9-11-39-12-10-32/h5-6,16-18,35H,7-15H2,1-4H3,(H,29,36)(H,31,37)/t18-/m0/s1 HRJPXCOYQFBVEX-SFHVURJKSA-N 344241 N-{6-[(2S)-2-(hydroxymethyl)-4-(morpholin-4-ylcarbonyl)piperazin-1-yl]-2-isopropoxypyridin-3-yl}-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 135 High affinity nerve growth factor receptor Human 2.30 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344241 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344241&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252800 385450329 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679713 CC(C)Oc1nc(ccc1NC(=O)c1coc2CC(C)(C)NC(=O)c12)N1CC[C@@H](C1)N(C)C InChI=1S/C24H33N5O4/c1-14(2)33-23-17(7-8-19(26-23)29-10-9-15(12-29)28(5)6)25-21(30)16-13-32-18-11-24(3,4)27-22(31)20(16)18/h7-8,13-15H,9-12H2,1-6H3,(H,25,30)(H,27,31)/t15-/m0/s1 LVHDWTLJQYKUGI-HNNXBMFYSA-N 344242 N-{6-[(3S)-3-(dimethylamino)pyrrolidin-1-yl]-2-isopropoxypyridin-3-yl}-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 136 High affinity nerve growth factor receptor Human 10.2 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344242 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344242&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252937 385450330 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679714 CC(C)Oc1nc(ccc1NC(=O)c1coc2CC(C)(C)NC(=O)c12)N1CCC[C@H](CO)C1 InChI=1S/C24H32N4O5/c1-14(2)33-23-17(7-8-19(26-23)28-9-5-6-15(11-28)12-29)25-21(30)16-13-32-18-10-24(3,4)27-22(31)20(16)18/h7-8,13-15,29H,5-6,9-12H2,1-4H3,(H,25,30)(H,27,31)/t15-/m0/s1 UREKZLLSJAUSIZ-HNNXBMFYSA-N 344243 N-{6-[(3S)-3-(hydroxymethyl)piperidin-1-yl]-2-isopropoxypyridin-3-yl}-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 137 High affinity nerve growth factor receptor Human 13.3 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344243 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344243&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252892 385450331 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679715 CC(C)Oc1nc(ccc1NC(=O)c1coc2CC(C)(C)NC(=O)c12)N1CCN([C@@H](CO)C1)C(C)=O InChI=1S/C25H33N5O6/c1-14(2)36-24-18(6-7-20(27-24)29-8-9-30(15(3)32)16(11-29)12-31)26-22(33)17-13-35-19-10-25(4,5)28-23(34)21(17)19/h6-7,13-14,16,31H,8-12H2,1-5H3,(H,26,33)(H,28,34)/t16-/m1/s1 XLOCJNRLTQQVSJ-MRXNPFEDSA-N 344244 N-{6-[(3R)-4-acetyl-3-(hydroxymethyl)piperazin-1-yl]-2-isopropoxypyridin-3-yl}-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 138 High affinity nerve growth factor receptor Human 6.30 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344244 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344244&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252759 385450332 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679716 CC(C)Oc1nc(ccc1NC(=O)c1coc2CC(C)(C)NC(=O)c12)N1CCN(C[C@@H]1CO)C(C)=O InChI=1S/C25H33N5O6/c1-14(2)36-24-18(6-7-20(27-24)30-9-8-29(15(3)32)11-16(30)12-31)26-22(33)17-13-35-19-10-25(4,5)28-23(34)21(17)19/h6-7,13-14,16,31H,8-12H2,1-5H3,(H,26,33)(H,28,34)/t16-/m1/s1 WNTJSUYENUORNM-MRXNPFEDSA-N 344245 N-{6-[(2R)-4-acetyl-2-(hydroxymethyl)piperazin-1-yl]-2-isopropoxypyridin-3-yl}-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 139 High affinity nerve growth factor receptor Human 2.40 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344245 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344245&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252993 385450333 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679717 CC(C)Oc1nc(ccc1NC(=O)c1coc2CC(C)(C)NC(=O)c12)N(CCO)CCO InChI=1S/C22H30N4O6/c1-13(2)32-21-15(5-6-17(24-21)26(7-9-27)8-10-28)23-19(29)14-12-31-16-11-22(3,4)25-20(30)18(14)16/h5-6,12-13,27-28H,7-11H2,1-4H3,(H,23,29)(H,25,30) GEFSUJZNMXWPSB-UHFFFAOYSA-N 344246 N-{6-[bis(2-hydroxyethyl)amino]-2-isopropoxypyridin-3-yl}-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamid::US9777020, Example 140 High affinity nerve growth factor receptor Human 10.5 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344246 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344246&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252804 385450334 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679718 COCCOc1ccc(NC(=O)c2coc3CC(C)(C)NC(=O)c23)c(OCCOC)n1 InChI=1S/C21H27N3O7/c1-21(2)11-15-17(19(26)24-21)13(12-31-15)18(25)22-14-5-6-16(29-9-7-27-3)23-20(14)30-10-8-28-4/h5-6,12H,7-11H2,1-4H3,(H,22,25)(H,24,26) KSVDOYQNCDDMCO-UHFFFAOYSA-N 344247 N-[2,6-bis(2-methoxyethoxy)pyridin-3-yl]-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 141 High affinity nerve growth factor receptor Human 60.1 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344247 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344247&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252777 385450335 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679719 COC[C@@H]1CN(CCN1C(C)=O)c1ccc(NC(=O)c2coc3CC(C)(C)NC(=O)c23)c(OCC(C)(C)O)n1 InChI=1S/C27H37N5O7/c1-16(33)32-10-9-31(12-17(32)13-37-6)21-8-7-19(25(29-21)39-15-27(4,5)36)28-23(34)18-14-38-20-11-26(2,3)30-24(35)22(18)20/h7-8,14,17,36H,9-13,15H2,1-6H3,(H,28,34)(H,30,35)/t17-/m0/s1 RVFKGFICULXNDY-KRWDZBQOSA-N 344248 N-{6-[(3S)-4-acetyl-3-(methoxymethyl)piperazin-1-yl]-2-(2-hydroxy-2-methylpropoxy)pyridin-3-yl}-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 142 High affinity nerve growth factor receptor Human 1.80 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344248 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344248&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253171 385450336 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679720 CCOc1nc(CCO)ccc1NC(=O)c1coc2CC(C)(C)NC(=O)c12 InChI=1S/C19H23N3O5/c1-4-26-18-13(6-5-11(20-18)7-8-23)21-16(24)12-10-27-14-9-19(2,3)22-17(25)15(12)14/h5-6,10,23H,4,7-9H2,1-3H3,(H,21,24)(H,22,25) GYSHNQWPMVRPQL-UHFFFAOYSA-N 344249 N-[2-ethoxy-6-(2-hydroxyethyl)pyridin-3-yl]-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 143 High affinity nerve growth factor receptor Human 24.6 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344249 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344249&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252886 385450337 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679721 CCOc1nc(CO)ccc1NC(=O)c1coc2CC(C)(C)NC(=O)c12 InChI=1S/C18H21N3O5/c1-4-25-17-12(6-5-10(8-22)19-17)20-15(23)11-9-26-13-7-18(2,3)21-16(24)14(11)13/h5-6,9,22H,4,7-8H2,1-3H3,(H,20,23)(H,21,24) DLMJGLDLCCGBSS-UHFFFAOYSA-N 344250 N-[2-ethoxy-6-(hydroxymethyl)pyridin-3-yl]-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 144 High affinity nerve growth factor receptor Human 49.2 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344250 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344250&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252945 385450338 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679722 CCOc1nc(ccc1NC(=O)c1coc2CC(C)(C)N(CCOC)C(=O)c12)C(O)=O InChI=1S/C21H25N3O7/c1-5-30-18-13(6-7-14(23-18)20(27)28)22-17(25)12-11-31-15-10-21(2,3)24(8-9-29-4)19(26)16(12)15/h6-7,11H,5,8-10H2,1-4H3,(H,22,25)(H,27,28) JYDUWDRHKRYRIT-UHFFFAOYSA-N 344251 6-ethoxy-5-({[5-(2-methoxyethyl)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridin-3-yl]carbonyl}amino)pyridine-2-carboxylic acid::US9777020, Example 145 High affinity nerve growth factor receptor Human 7.90 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344251 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344251&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252899 385450339 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679723 Cn1ncc2cc(NC(=O)c3coc4CC(C)(C)CC(=O)c34)ccc12 InChI=1S/C19H19N3O3/c1-19(2)7-15(23)17-13(10-25-16(17)8-19)18(24)21-12-4-5-14-11(6-12)9-20-22(14)3/h4-6,9-10H,7-8H2,1-3H3,(H,21,24) QNZWOOMHXSDHJI-UHFFFAOYSA-N 344252 6,6-dimethyl-N-(1-methyl-1H-indazol-5-yl)-4-oxo-4,5,6,7-tetrahydro-1-benzofuran-3-carboxamide::US9777020, Example 146 High affinity nerve growth factor receptor Human 34.1 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344252 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344252&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253122 385450340 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679724 Cn1cc2cc(NC(=O)c3coc4CC(C)(C)CC(=O)c34)ccc2n1 InChI=1S/C19H19N3O3/c1-19(2)7-15(23)17-13(10-25-16(17)8-19)18(24)20-12-4-5-14-11(6-12)9-22(3)21-14/h4-6,9-10H,7-8H2,1-3H3,(H,20,24) AWLILQRSUVZLQU-UHFFFAOYSA-N 344253 6,6-dimethyl-N-(2-methyl-2H-indazol-5-yl)-4-oxo-4,5,6,7-tetrahydro-1-benzofuran-3-carboxamide::US9777020, Example 147 High affinity nerve growth factor receptor Human 16.1 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344253 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344253&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252910 385450341 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679725 CC(=O)N1CCN(CC1)c1ccc(NC(=O)c2coc3CC(C)(C)CC(=O)c23)cc1 InChI=1S/C23H27N3O4/c1-15(27)25-8-10-26(11-9-25)17-6-4-16(5-7-17)24-22(29)18-14-30-20-13-23(2,3)12-19(28)21(18)20/h4-7,14H,8-13H2,1-3H3,(H,24,29) WQAKVRUJQUEZBX-UHFFFAOYSA-N 344254 N-[4-(4-acetylpiperazin-1-yl)phenyl]-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1-benzofuran-3-carboxamide::US9777020, Example 148 High affinity nerve growth factor receptor Human 32.4 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344254 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344254&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253097 385450342 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679726 CC1(C)Cc2occ(C(=O)Nc3ccc(nc3)N3CCNCC3)c2C(=O)C1 InChI=1S/C20H24N4O3/c1-20(2)9-15(25)18-14(12-27-16(18)10-20)19(26)23-13-3-4-17(22-11-13)24-7-5-21-6-8-24/h3-4,11-12,21H,5-10H2,1-2H3,(H,23,26) AMHWCNJLBSLVJO-UHFFFAOYSA-N 344255 6,6-dimethyl-4-oxo-N-[6-(piperazin-1-yl)pyridin-3-yl]-4,5,6,7-tetrahydro-1-benzofuran-3-carboxamide::US9777020, Example 149 High affinity nerve growth factor receptor Human 135 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344255 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344255&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253031 385450343 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679727 Cn1cc2cc(NC(=O)c3coc4CC5(CCC5)CC(=O)c34)ccc2n1 InChI=1S/C20H19N3O3/c1-23-10-12-7-13(3-4-15(12)22-23)21-19(25)14-11-26-17-9-20(5-2-6-20)8-16(24)18(14)17/h3-4,7,10-11H,2,5-6,8-9H2,1H3,(H,21,25) ADBWCNSBKNIKRO-UHFFFAOYSA-N 344256 N-(2-methyl-2H-indazol-5-yl)-4-oxo-4,7-dihydro-5H-spiro[1-benzofuran-6,1′-cyclobutane]-3-carboxamide::US9777020, Example 150 High affinity nerve growth factor receptor Human 43.2 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344256 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344256&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252893 385450344 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679728 CC1(C)Cc2occ(C(=O)Nc3ccc(cn3)N3CCNCC3)c2C(=O)C1 InChI=1S/C20H24N4O3/c1-20(2)9-15(25)18-14(12-27-16(18)10-20)19(26)23-17-4-3-13(11-22-17)24-7-5-21-6-8-24/h3-4,11-12,21H,5-10H2,1-2H3,(H,22,23,26) BWUYCIMAUSHUBA-UHFFFAOYSA-N 344257 6,6-dimethyl-4-oxo-N-[5-(piperazin-1-yl)pyridin-2-yl]-4,5,6,7-tetrahydro-1-benzofuran-3-carboxamide::US9777020, Example 151 High affinity nerve growth factor receptor Human 63.4 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344257 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344257&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253133 385450345 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679729 CC1(C)Cc2occ(C(=O)Nc3ccc(cc3)N3CCN(CC3)S(C)(=O)=O)c2C(=O)C1 InChI=1S/C22H27N3O5S/c1-22(2)12-18(26)20-17(14-30-19(20)13-22)21(27)23-15-4-6-16(7-5-15)24-8-10-25(11-9-24)31(3,28)29/h4-7,14H,8-13H2,1-3H3,(H,23,27) GVASYZXSFDPVFX-UHFFFAOYSA-N 344258 6,6-dimethyl-N-{4-[4-(methylsulfonyl)piperazin-1-yl]phenyl}-4-oxo-4,5,6,7-tetrahydro-1-benzofuran-3-carboxamide::US9777020, Example 152 High affinity nerve growth factor receptor Human 35.8 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344258 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344258&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253096 385450346 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679730 CC1(C)Cc2occ(C(=O)Nc3ccc4nn(CCO)cc4c3)c2C(=O)C1 InChI=1S/C20H21N3O4/c1-20(2)8-16(25)18-14(11-27-17(18)9-20)19(26)21-13-3-4-15-12(7-13)10-23(22-15)5-6-24/h3-4,7,10-11,24H,5-6,8-9H2,1-2H3,(H,21,26) JBENUHNXZSRVNG-UHFFFAOYSA-N 344259 N-[2-(2-hydroxyethyl)-2H-indazol-5-yl]-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1-benzofuran-3-carboxamide::US9777020, Example 153 High affinity nerve growth factor receptor Human 45.6 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344259 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344259&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252784 385450347 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679731 CC1(C)Cc2occ(C(=O)Nc3ccc4[nH]c(CO)nc4c3)c2C(=O)C1 InChI=1S/C19H19N3O4/c1-19(2)6-14(24)17-11(9-26-15(17)7-19)18(25)20-10-3-4-12-13(5-10)22-16(8-23)21-12/h3-5,9,23H,6-8H2,1-2H3,(H,20,25)(H,21,22) CTLWUAWKCHYJQX-UHFFFAOYSA-N 344260 N-[2-(hydroxymethyl)-1H-benzimidazol-5-yl]-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1-benzofuran-3-carboxamide::US9777020, Example 154 High affinity nerve growth factor receptor Human 74.0 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344260 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344260&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252754 385450348 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679732 CC1(C)Cc2occ(C(=O)Nc3ccc(cn3)N3CCN(CC3)S(C)(=O)=O)c2C(=O)C1 InChI=1S/C21H26N4O5S/c1-21(2)10-16(26)19-15(13-30-17(19)11-21)20(27)23-18-5-4-14(12-22-18)24-6-8-25(9-7-24)31(3,28)29/h4-5,12-13H,6-11H2,1-3H3,(H,22,23,27) CUIYONMOCMZPPT-UHFFFAOYSA-N 344261 6,6-dimethyl-N-{5-[4-(methylsulfonyl)piperazin-1-yl]pyridin-2-yl}-4-oxo-4,5,6,7-tetrahydro-1-benzofuran-3-carboxamide::US9777020, Example 155 High affinity nerve growth factor receptor Human 54.8 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344261 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344261&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252986 385450349 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679733 CC(=O)N1CCN(CC1)c1ccc(NC(=O)c2coc3CC(C)(C)CC(=O)c23)nc1 InChI=1S/C22H26N4O4/c1-14(27)25-6-8-26(9-7-25)15-4-5-19(23-12-15)24-21(29)16-13-30-18-11-22(2,3)10-17(28)20(16)18/h4-5,12-13H,6-11H2,1-3H3,(H,23,24,29) UQSUKUPIVBZCHJ-UHFFFAOYSA-N 344262 N-[5-(4-acetylpiperazin-1-yl)pyridin-2-yl]-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1-benzofuran-3-carboxamide::US9777020, Example 156 High affinity nerve growth factor receptor Human 46.7 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344262 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344262&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253032 385450350 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679734 COc1cc(ccc1NC(=O)c1coc2CC(C)(C)CC(=O)c12)N1CCNCC1 InChI=1S/C22H27N3O4/c1-22(2)11-17(26)20-15(13-29-19(20)12-22)21(27)24-16-5-4-14(10-18(16)28-3)25-8-6-23-7-9-25/h4-5,10,13,23H,6-9,11-12H2,1-3H3,(H,24,27) SPZVYCOKWACRIW-UHFFFAOYSA-N 344263 N-[2-methoxy-4-(piperazin-1-yl)phenyl]-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1-benzofuran-3-carboxamide::US9777020, Example 157 High affinity nerve growth factor receptor Human 6.40 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344263 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344263&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253145 385450351 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679735 COc1cc(ccc1NC(=O)c1coc2CC(C)(C)CC(=O)c12)N1CCN(CC1)C(C)=O InChI=1S/C24H29N3O5/c1-15(28)26-7-9-27(10-8-26)16-5-6-18(20(11-16)31-4)25-23(30)17-14-32-21-13-24(2,3)12-19(29)22(17)21/h5-6,11,14H,7-10,12-13H2,1-4H3,(H,25,30) NFNDUWXRLSREQS-UHFFFAOYSA-N 344264 N-[4-(4-acetylpiperazin-1-yl)-2-methoxyphenyl]-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydro-1-benzofuran-3-carboxamide::US9777020, Example 158 High affinity nerve growth factor receptor Human 4.20 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344264 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344264&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252811 385450352 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679736 Cn1cc2cc(NC(=O)c3coc4CC5(CC5)CC(=O)c34)ccc2n1 InChI=1S/C19H17N3O3/c1-22-9-11-6-12(2-3-14(11)21-22)20-18(24)13-10-25-16-8-19(4-5-19)7-15(23)17(13)16/h2-3,6,9-10H,4-5,7-8H2,1H3,(H,20,24) JCVHUCSVCSRZQH-UHFFFAOYSA-N 344265 N-(2-methyl-2H-indazol-5-yl)-4-oxo-4,7-dihydro-5H-spiro[1-benzofuran-6,1′-cyclopropane]-3-carboxamide::US9777020, Example 159 High affinity nerve growth factor receptor Human 10.3 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344265 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344265&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253134 385450353 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679737 Cn1cc2cc(NC(=O)c3coc4CNCC(=O)c34)ccc2n1 InChI=1S/C16H14N4O3/c1-20-7-9-4-10(2-3-12(9)19-20)18-16(22)11-8-23-14-6-17-5-13(21)15(11)14/h2-4,7-8,17H,5-6H2,1H3,(H,18,22) UFMWJNGYUGPBAV-UHFFFAOYSA-N 344266 N-(2-methyl-2H-indazol-5-yl)-4-oxo-4,5,6,7-tetrahydrofuro[2,3-c]pyridine-3-carboxamide::US9777020, Example 160 High affinity nerve growth factor receptor Human 258 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344266 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344266&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253064 385450354 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679738 Cn1cc2cc(NC(=O)c3coc4CN(CC(=O)c34)S(C)(=O)=O)ccc2n1 InChI=1S/C17H16N4O5S/c1-20-6-10-5-11(3-4-13(10)19-20)18-17(23)12-9-26-15-8-21(27(2,24)25)7-14(22)16(12)15/h3-6,9H,7-8H2,1-2H3,(H,18,23) YOCUDSXSIPVXJF-UHFFFAOYSA-N 344267 N-(2-methyl-2H-indazol-5-yl)-6-(methylsulfonyl)-4-oxo-4,5,6,7-tetrahydrofuro[2,3-c]pyridine-3-carboxamide::US9777020, Example 161 High affinity nerve growth factor receptor Human 872 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344267 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344267&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253013 385450355 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679739 Cn1cc2cc(NC(=O)c3coc4CC(C)(CC(=O)c34)C(N)=O)ccc2n1 InChI=1S/C19H18N4O4/c1-19(18(20)26)6-14(24)16-12(9-27-15(16)7-19)17(25)21-11-3-4-13-10(5-11)8-23(2)22-13/h3-5,8-9H,6-7H2,1-2H3,(H2,20,26)(H,21,25) UTFPUEDACBGUDY-UHFFFAOYSA-N 344268 6-methyl-N3-(2-methyl-2H-indazol-5-yl)-4-oxo-4,5,6,7-tetrahydro-1-benzofuran-3,6-dicarboxamide::US9777020, Example 162 High affinity nerve growth factor receptor Human 58.0 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344268 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344268&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252796 385450356 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679740 COC(=O)C1(C)Cc2occ(C(=O)Nc3ccc4nn(C)cc4c3)c2C(=O)C1 InChI=1S/C20H19N3O5/c1-20(19(26)27-3)7-15(24)17-13(10-28-16(17)8-20)18(25)21-12-4-5-14-11(6-12)9-23(2)22-14/h4-6,9-10H,7-8H2,1-3H3,(H,21,25) HASHONQSUXMIFH-UHFFFAOYSA-N 344269 US9777020, Example 163::methyl 6-methyl-3-[(2-methyl-2H-indazol-5-yl)carbamoyl]-4-oxo-4,5,6,7-tetrahydro-1-benzofuran-6-carboxylate High affinity nerve growth factor receptor Human 156 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344269 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344269&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253148 385450357 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679741 Cn1cc2cc(NC(=O)c3coc4CC(C)(CO)CC(=O)c34)ccc2n1 InChI=1S/C19H19N3O4/c1-19(10-23)6-15(24)17-13(9-26-16(17)7-19)18(25)20-12-3-4-14-11(5-12)8-22(2)21-14/h3-5,8-9,23H,6-7,10H2,1-2H3,(H,20,25) RDYBJNKQKNEORI-UHFFFAOYSA-N 344270 6-(hydroxymethyl)-6-methyl-N-(2-methyl-2H-indazol-5-yl)-4-oxo-4,5,6,7-tetrahydro-1-benzofuran-3-carboxamide::US9777020, Example 164 High affinity nerve growth factor receptor Human 21.9 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344270 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344270&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253047 385450358 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679742 COc1cc(ccc1NC(=O)c1coc2CC(C)(CO)CC(=O)c12)N1CCN(CC1)C(=O)OC(C)(C)C InChI=1S/C27H35N3O7/c1-26(2,3)37-25(34)30-10-8-29(9-11-30)17-6-7-19(21(12-17)35-5)28-24(33)18-15-36-22-14-27(4,16-31)13-20(32)23(18)22/h6-7,12,15,31H,8-11,13-14,16H2,1-5H3,(H,28,33) PQQRQMFMLBOGRJ-UHFFFAOYSA-N 344271 US9777020, Example 165::tert-butyl 4-[4-({[6-(hydroxymethyl)-6-methyl-4-oxo-4,5,6,7-tetrahydro-1-benzofuran-3-yl]carbonyl}amino)-3-methoxyphenyl]piperazine-1-carboxylate High affinity nerve growth factor receptor Human 13.3 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344271 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344271&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252942 385450359 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679743 COCC1(C)Cc2occ(C(=O)Nc3ccc(cc3OC)N3CCNCC3)c2C(=O)C1 InChI=1S/C23H29N3O5/c1-23(14-29-2)11-18(27)21-16(13-31-20(21)12-23)22(28)25-17-5-4-15(10-19(17)30-3)26-8-6-24-7-9-26/h4-5,10,13,24H,6-9,11-12,14H2,1-3H3,(H,25,28) JTTPNDYKANJNLL-UHFFFAOYSA-N 344272 6-(methoxymethyl)-N-[2-methoxy-4-(piperazin-1-yl)phenyl]-6-methyl-4-oxo-4,5,6,7-tetrahydro-1-benzofuran-3-carboxamide::US9777020, Example 166 High affinity nerve growth factor receptor Human 104 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344272 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344272&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252983 385450360 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679744 Cn1cc2cc(NC(=O)c3coc4CCC(C)(CO)C(=O)c34)ccc2n1 InChI=1S/C19H19N3O4/c1-19(10-23)6-5-15-16(17(19)24)13(9-26-15)18(25)20-12-3-4-14-11(7-12)8-22(2)21-14/h3-4,7-9,23H,5-6,10H2,1-2H3,(H,20,25) XCHXFESZBFYXGW-UHFFFAOYSA-N 344273 5-(hydroxymethyl)-5-methyl-N-(2-methyl-2H-indazol-5-yl)-4-oxo-4,5,6,7-tetrahydro-1-benzofuran-3-carboxamide::US9777020, Example 167 High affinity nerve growth factor receptor Human 35.3 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344273 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344273&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252859 385450361 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679745 Cn1cc2cc(NC(=O)c3coc4CCC(C)(C)C(=O)c34)ccc2n1 InChI=1S/C19H19N3O3/c1-19(2)7-6-15-16(17(19)23)13(10-25-15)18(24)20-12-4-5-14-11(8-12)9-22(3)21-14/h4-5,8-10H,6-7H2,1-3H3,(H,20,24) SWUYQDCYVWZQGV-UHFFFAOYSA-N 344274 5,5-dimethyl-N-(2-methyl-2H-indazol-5-yl)-4-oxo-4,5,6,7-tetrahydro-1-benzofuran-3-carboxamide::US9777020, Example 168 High affinity nerve growth factor receptor Human 5.90 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344274 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344274&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252996 385450362 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679746 COc1cc(ccc1NC(=O)c1coc2CCC(C)(CN)C(=O)c12)N1CCN(CC1)C(C)=O InChI=1S/C24H30N4O5/c1-15(29)27-8-10-28(11-9-27)16-4-5-18(20(12-16)32-3)26-23(31)17-13-33-19-6-7-24(2,14-25)22(30)21(17)19/h4-5,12-13H,6-11,14,25H2,1-3H3,(H,26,31) YXPVRCLOCJKYOM-UHFFFAOYSA-N 344275 N-[4-(4-acetylpiperazin-1-yl)-2-methoxyphenyl]-5-(aminomethyl)-5-methyl-4-oxo-4,5,6,7-tetrahydro-1-benzofuran-3-carboxamide::US9777020, Example 169 High affinity nerve growth factor receptor Human 59.6 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344275 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344275&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252852 385450363 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679747 COc1cc(ccc1NC(=O)c1coc2COC3(CCNCC3)C(=O)c12)N1CCN(CC1)C(C)=O InChI=1S/C25H30N4O6/c1-16(30)28-9-11-29(12-10-28)17-3-4-19(20(13-17)33-2)27-24(32)18-14-34-21-15-35-25(23(31)22(18)21)5-7-26-8-6-25/h3-4,13-14,26H,5-12,15H2,1-2H3,(H,27,32) XJUBPXPSXCLRJZ-UHFFFAOYSA-N 344276 N-[4-(4-acetylpiperazin-1-yl)-2-methoxyphenyl]-4-oxo-4,7-dihydrospiro[furo[2,3-c]pyran-5,4′-piperidine]-3-carboxamide::US9777020, Example 170 High affinity nerve growth factor receptor Human 56.5 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344276 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344276&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252919 385450364 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679748 COc1nc(ccc1NC(=O)c1coc2COC(C)(C)C(=O)c12)N1CCN(CC1)C(C)=O InChI=1S/C22H26N4O6/c1-13(27)25-7-9-26(10-8-25)17-6-5-15(21(24-17)30-4)23-20(29)14-11-31-16-12-32-22(2,3)19(28)18(14)16/h5-6,11H,7-10,12H2,1-4H3,(H,23,29) ZGHNQGBDTVTZFT-UHFFFAOYSA-N 344277 N-[6-(4-acetylpiperazin-1-yl)-2-methoxypyridin-3-yl]-5,5-dimethyl-4-oxo-4,7-dihydro-5H-furo[2,3-c]pyran-3-carboxamide::US9777020, Example 171 High affinity nerve growth factor receptor Human 2.90 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344277 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344277&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253105 385450365 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679749 COc1cc(ccc1NC(=O)c1coc2COC3(COC3)C(=O)c12)N1CCN(CC1)C(C)=O InChI=1S/C23H25N3O7/c1-14(27)25-5-7-26(8-6-25)15-3-4-17(18(9-15)30-2)24-22(29)16-10-32-19-11-33-23(12-31-13-23)21(28)20(16)19/h3-4,9-10H,5-8,11-13H2,1-2H3,(H,24,29) CXBZWOWCBMNVJF-UHFFFAOYSA-N 344278 N-[4-(4-acetylpiperazin-1-yl)-2-methoxyphenyl]-4-oxo-4,7-dihydrospiro[furo[2,3-c]pyran-5,3′-oxetane]-3-carboxamide::US9777020, Example 172 High affinity nerve growth factor receptor Human 60.0 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344278 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344278&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253063 385450366 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679750 CCOc1nc(ccc1NC(=O)c1coc2CC(C)(C)N(C)C(=O)c12)N1CCN(CC1)C(C)=O InChI=1S/C24H31N5O5/c1-6-33-22-17(7-8-19(26-22)29-11-9-28(10-12-29)15(2)30)25-21(31)16-14-34-18-13-24(3,4)27(5)23(32)20(16)18/h7-8,14H,6,9-13H2,1-5H3,(H,25,31) XYHZHWGJEUKZIR-UHFFFAOYSA-N 344279 N-[6-(4-acetylpiperazin-1-yl)-2-ethoxypyridin-3-yl]-5,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 173 High affinity nerve growth factor receptor Human 3.50 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344279 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344279&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252897 385450367 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679751 CCOc1nc(ccc1NC(=O)c1coc2CC(C)(C)N(CCO)C(=O)c12)N1CCN(CC1)C(C)=O InChI=1S/C25H33N5O6/c1-5-35-23-18(6-7-20(27-23)29-10-8-28(9-11-29)16(2)32)26-22(33)17-15-36-19-14-25(3,4)30(12-13-31)24(34)21(17)19/h6-7,15,31H,5,8-14H2,1-4H3,(H,26,33) SFQKFUNBQGNUPL-UHFFFAOYSA-N 344280 N-[6-(4-acetylpiperazin-1-yl)-2-ethoxypyridin-3-yl]-5-(2-hydroxyethyl)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 174 High affinity nerve growth factor receptor Human 5.20 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344280 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344280&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253091 385450368 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679752 CCOc1nc(ccc1NC(=O)c1coc2CC(C)(C)N(CCOC)C(=O)c12)N1CCN(CC1)C(C)=O InChI=1S/C26H35N5O6/c1-6-36-24-19(7-8-21(28-24)30-11-9-29(10-12-30)17(2)32)27-23(33)18-16-37-20-15-26(3,4)31(13-14-35-5)25(34)22(18)20/h7-8,16H,6,9-15H2,1-5H3,(H,27,33) DCDPFYPTBKXPEC-UHFFFAOYSA-N 344281 N-[6-(4-acetylpiperazin-1-yl)-2-ethoxypyridin-3-yl]-5-(2-methoxyethyl)-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 175 High affinity nerve growth factor receptor Human 4.70 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344281 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344281&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252812 385450369 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679753 CCOc1nc(ccc1NC(=O)c1coc2CC(C)(C)N(CCOCCO)C(=O)c12)N1CCN(CC1)C(C)=O InChI=1S/C27H37N5O7/c1-5-38-25-20(6-7-22(29-25)31-10-8-30(9-11-31)18(2)34)28-24(35)19-17-39-21-16-27(3,4)32(26(36)23(19)21)12-14-37-15-13-33/h6-7,17,33H,5,8-16H2,1-4H3,(H,28,35) RSJBSBOAUWEEPV-UHFFFAOYSA-N 344282 N-[6-(4-acetylpiperazin-1-yl)-2-ethoxypyridin-3-yl]-5-[2-(2-hydroxyethoxyl)ethyl]-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 176 High affinity nerve growth factor receptor Human 2.10 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344282 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344282&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252829 385450370 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679754 COCCOc1nc(ccc1NC(=O)c1coc2CC(C)(C)NC(=O)c12)N1CCN(CC1)C(C)=O InChI=1S/C24H31N5O6/c1-15(30)28-7-9-29(10-8-28)19-6-5-17(23(26-19)34-12-11-33-4)25-21(31)16-14-35-18-13-24(2,3)27-22(32)20(16)18/h5-6,14H,7-13H2,1-4H3,(H,25,31)(H,27,32) XIRZZCCIBZBOPS-UHFFFAOYSA-N 344283 N-[6-(4-acetylpiperazin-1-yl)-2-(2-methoxyethoxyl)pyridin-3-yl]-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 177 High affinity nerve growth factor receptor Human 12.2 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344283 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344283&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253120 385450371 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679755 CC(=O)N1CCN(CC1)c1ccc(NC(=O)c2coc3CC(C)(C)NC(=O)c23)c(OCC(F)(F)F)n1 InChI=1S/C23H26F3N5O5/c1-13(32)30-6-8-31(9-7-30)17-5-4-15(21(28-17)36-12-23(24,25)26)27-19(33)14-11-35-16-10-22(2,3)29-20(34)18(14)16/h4-5,11H,6-10,12H2,1-3H3,(H,27,33)(H,29,34) QXJGBXAIRCVGMF-UHFFFAOYSA-N 344284 N-[6-(4-acetylpiperazin-1-yl)-2-(2,2,2-trifluoroethoxyl)pyridin-3-yl]-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 178 High affinity nerve growth factor receptor Human 5.20 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344284 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344284&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253040 385450372 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679756 CC(=O)N1CCN(CC1)c1ccc(NC(=O)c2coc3CC(C)(C)NC(=O)c23)c(OC2COC2)n1 InChI=1S/C24H29N5O6/c1-14(30)28-6-8-29(9-7-28)19-5-4-17(23(26-19)35-15-11-33-12-15)25-21(31)16-13-34-18-10-24(2,3)27-22(32)20(16)18/h4-5,13,15H,6-12H2,1-3H3,(H,25,31)(H,27,32) VOOMVSFOTQUOGX-UHFFFAOYSA-N 344285 N-[6-(4-acetylpiperazin-1-yl)-2-(oxetan-3-yloxy)pyridin-3-yl]-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 179 High affinity nerve growth factor receptor Human 4.90 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344285 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344285&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252915 385450373 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679757 CC(=O)N1CCN(CC1)c1ccc(NC(=O)c2coc3CC(C)(C)NC(=O)c23)c(OC2CCOCC2)n1 InChI=1S/C26H33N5O6/c1-16(32)30-8-10-31(11-9-30)21-5-4-19(25(28-21)37-17-6-12-35-13-7-17)27-23(33)18-15-36-20-14-26(2,3)29-24(34)22(18)20/h4-5,15,17H,6-14H2,1-3H3,(H,27,33)(H,29,34) QRAUOFCRDLODOA-UHFFFAOYSA-N 344286 N-[6-(4-acetylpiperazin-1-yl)-2-(tetrahydro-2H-pyran-4-yloxy)pyridin-3-yl]-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 180 High affinity nerve growth factor receptor Human 11.0 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344286 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344286&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253008 385450374 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679758 CC(=O)N1CCN(CC1)c1ccc(NC(=O)c2coc3CC(C)(C)NC(=O)c23)c(O[C@H]2CCOC2)n1 InChI=1S/C25H31N5O6/c1-15(31)29-7-9-30(10-8-29)20-5-4-18(24(27-20)36-16-6-11-34-13-16)26-22(32)17-14-35-19-12-25(2,3)28-23(33)21(17)19/h4-5,14,16H,6-13H2,1-3H3,(H,26,32)(H,28,33)/t16-/m0/s1 QUEOXNKWNPVBDQ-INIZCTEOSA-N 344287 N-{6-(4-acetylpiperazin-1-yl)-2-[(3S)-tetrahydrofuran-3-yloxy]pyridin-3-yl}-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 181 High affinity nerve growth factor receptor Human 10.2 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344287 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344287&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253009 385450375 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679759 COCCOc1nc(ccc1NC(=O)c1coc2CC(C)(C)NC(=O)c12)N1CCN(CC1)C=O InChI=1S/C23H29N5O6/c1-23(2)12-17-19(21(31)26-23)15(13-34-17)20(30)24-16-4-5-18(25-22(16)33-11-10-32-3)28-8-6-27(14-29)7-9-28/h4-5,13-14H,6-12H2,1-3H3,(H,24,30)(H,26,31) BRFOBNXLKVNMND-UHFFFAOYSA-N 344288 N-[6-(4-formylpiperazin-1-yl)-2-(2-methoxyethoxyl)pyridin-3-yl]-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 182 High affinity nerve growth factor receptor Human 17.8 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344288 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344288&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252908 385450376 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679760 CC(=O)N1CCN(CC1)c1ccc(NC(=O)c2coc3CC(C)(C)NC(=O)c23)c(OC2CS(=O)C2)n1 InChI=1S/C24H29N5O6S/c1-14(30)28-6-8-29(9-7-28)19-5-4-17(23(26-19)35-15-12-36(33)13-15)25-21(31)16-11-34-18-10-24(2,3)27-22(32)20(16)18/h4-5,11,15H,6-10,12-13H2,1-3H3,(H,25,31)(H,27,32) CZWCJBGSWWLKIH-UHFFFAOYSA-N 344289 N-{6-(4-acetylpiperazin-1-yl)-2-[(1-oxidothietan-3-yl)oxy]pyridin-3-yl}-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 183 High affinity nerve growth factor receptor Human 4.80 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344289 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344289&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118252912 385450377 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679761 CCOc1nc(ccc1NC(=O)c1coc2CC(C)(C)NC(=O)c12)C1CCN(CC1)C(C)=O InChI=1S/C24H30N4O5/c1-5-32-23-18(7-6-17(26-23)15-8-10-28(11-9-15)14(2)29)25-21(30)16-13-33-19-12-24(3,4)27-22(31)20(16)19/h6-7,13,15H,5,8-12H2,1-4H3,(H,25,30)(H,27,31) RIFHGMKOQSKFJV-UHFFFAOYSA-N 344290 N-[6-(1-acetylpiperidin-4-yl)-2-ethoxypyridin-3-yl]-6,6-dimethyl-4-oxo-4,5,6,7-tetrahydrofuro[3,2-c]pyridine-3-carboxamide::US9777020, Example 184 High affinity nerve growth factor receptor Human 3.50 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344290 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344290&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253020 385450378 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7 679762 CCOc1nc(ccc1NC(=O)c1coc2CCC(C(=O)c12)c1cc(F)ccc1F)N1CCN(CC1)C(C)=O InChI=1S/C28H28F2N4O5/c1-3-38-28-22(7-9-24(32-28)34-12-10-33(11-13-34)16(2)35)31-27(37)20-15-39-23-8-5-18(26(36)25(20)23)19-14-17(29)4-6-21(19)30/h4,6-7,9,14-15,18H,3,5,8,10-13H2,1-2H3,(H,31,37) DRDORUYKJJKCKM-UHFFFAOYSA-N 344291 N-[6-(4-acetylpiperazin-1-yl)-2-ethoxypyridin-3-yl]-5-(2,5-difluorophenyl)-4-oxo-4,5,6,7-tetrahydro-1-benzofuran-3-carboxamide::US9777020, Example 185 High affinity nerve growth factor receptor Human 6.60 US Patent 10.7270/Q2T155R7 US9777020 Altenbach, RJ; Liu, H; Clapham, B; Aguirre, AL; Cowart, M; Koenig, JR; Sarris, K; Scanio, MJ; Swinger, KK; Vasudevan, A; Villamil, CI; Woller, KR 10/3/2017 8/13/2019 AbbVie Inc http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=344291 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3688&target=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=344291&enzyme=High+affinity+nerve+growth+factor+receptor&column=ki&startPg=0&Increment=50&submit=Search 118253081 385450379 1 MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG 1WWA,1WWW,2IFG,4AOJ,4F0I,4PMM,4PMP,4PMS,4PMT,4YNE,4YPS,5H3Q,5I8A,5JFS,5JFV,5JFW,5JFX,5KMI,5KMJ,5KMK,5KML,5KMM,5KMN,5KMO,5KVT,5WR7,6D1Y,6D1Z,6D20,6D22,6DKB,6DKG,6DKI,6DKW,6IQN,6J5L,6NPT,6NSP,6NSS,6PL1,6PL2,6PL3,6PL4,6PMA,6PMB,6PMC,6PME,7VKO,7XAF,7XBI High affinity nerve growth factor receptor NTRK1_HUMAN P04629 B2R6T5 B7ZM34 P08119 Q15655 Q15656 Q5D056 Q5VZS2 Q7Z5C3 Q9UIU7